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Abstract: 
Fred Sanger, the inventor of the first protein, RNA and DNA sequencing methods, 
has traditionally been seen as a technical scientist, engaged in laboratory bench work 
and not interested at all in intellectual debates in biology. In his autobiography and 
commentaries by fellow researchers, he is portrayed as having a trajectory exclusively 
dependent on technological progress. The scarce historical scholarship on Sanger 
partially challenges these accounts by highlighting the importance of professional 
contacts, institutional and disciplinary moves in his career, spanning from 1940 to 
1983. This paper will complement such literature by focusing, for the first time, on 
the transition of Sanger’s sequencing strategies from degrading to copying the target 
molecule, which occurred in the late 60s as he was shifting from protein and RNA to 
DNA sequencing, shortly after his move from the Department of Biochemistry to the 
Laboratory of Molecular Biology, both based in Cambridge (UK). Through a 
reinterpretation of Sanger’s papers and retrospective accounts and a pioneering 
investigation of his laboratory notebooks, I will claim that sequencing shifted from 
the working procedures of organic chemistry to those of the emergent molecular 
biology. I will also argue that sequencing deserves a history in its own right as a 
practice and not as a technique subordinated to the development of molecular biology 
or genomics. My proposed history of sequencing leads to a reappraisal of current STS 
debates on bioinformatics, biotechnology and biomedicine. 
 
Keywords: Sanger, sequencing, molecular biology, biochemistry, genomics, 
recombinant DNA, proteins. 
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“Of the three main activities involved in scientific research, thinking, talking, and doing, I much prefer 
the last and am probably best at it. I am all right at the thinking, but not much good at the talking. 
Doing for a scientist implies doing experiments, and I managed to work in the laboratory as my main 
occupation from 1940 (…) until I retired in 1983. Unlike most of my scientific colleagues, I was not 
academically brilliant. I never won scholarships and would probably not have been able to attend 
Cambridge University if my parents had not been fairly rich; however, when it came to research where 
experiments were of paramount importance and fairly narrow specialization was helpful, I managed to 
hold my own even with the most academically outstanding”. 2 
 
 
It is an interesting paradox that a leading scientific figure such as Fred Sanger, 
awarded two Nobel Prizes for his pioneering protein and DNA sequencing methods 
(1959 and 80), has received little attention by STS scholars. There are, literally, two 
historical papers on his career 3 and small summaries of his contributions in popular 
works, mainly on the Human Genome Project. In these latter accounts, Sanger is seen 
as a precursor of genomics, bioinformatics and biotechnology, by permitting to 
determine, with his techniques, the sequence of nucleotides in the DNA molecule. 
Sanger’s portrayal as an avant-garde reflects a wider anti-historical view which 
considers sequencing the culmination of a series of revolutions in molecular biology, 
starting with the elucidation of the double helix of DNA (1953) and leading, in a 
straight line, to the recombinant techniques, genomics and the new 1980s 
biosciences.4 
 
This linear and teleological view has been reinforced by Sanger’s much quoted 
autobiographical paper, “Sequences, sequences and sequences,” which considers his 
methods as mainly dependent on the availability, at each historical moment, of 
instruments for treating the protein, RNA and DNA molecules. In further interviews – 
including one with myself – Sanger has maintained this interpretation, endorsed in a 
number of accounts by his collaborators and fellow scientists. 5  The accounts of 
Sanger and colleagues have informed the popular and growing contemporary STS 
literature on genomics, which understands sequencing as a series of methods deriving 
from progress in the recombinant DNA techniques during the 1970s, and allowing, 
the following decade, the Human Genome Project and other revolutionary 
endeavors.6 
 
The historiography of 20th century life sciences has not yet systematically challenged 
these accounts.7 An exception is Soraya de Chadarevian, who in the only historical 
investigations about Sanger stresses both the complexities in the trajectory of 
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sequencing – beyond that of recombinant DNA and genomics – and the importance of 
the research environments surrounding the technologies. Sanger’s professional 
contacts and institutional settings – especially after his 1962 move from the 
Department of Biochemistry to the Laboratory of Molecular Biology of Cambridge, 
UK – were essential for the development of sequencing from proteins to RNA and 
DNA. Equally, the introduction of sequencing into a molecular biology laboratory 
shaped the emergence of this discipline in Cambridge, the first British city where it 
was coined.8 
 
De Chadarevian, thus, thoroughly analyzes the emergence of Sanger’s first protein 
sequencing methods and their incorporation into the technical repertoire of molecular 
biology. There is, however, little attention to Sanger’s further work on RNA and 
DNA sequencing during the 1960s and 70s. This period, especially the latter decade, 
was marked by the emergence of a “new approach” in his sequencing strategy: 
instead of successively cleaving and then reconstructing the molecule target of 
sequencing, Sanger attempted to copy it and use the resulting duplicate in deducing 
the sequence. In her latest paper, de Chadarevian argues that Sanger’s early protein 
techniques “informed initial attempts at nucleic acid sequencing”. Nevertheless, little 
is said about how RNA and DNA sequencing evolved, and especially what was 
behind Sanger’s change of approach.9 
 
My paper will address Sanger’s transition from degrading to copying procedures and 
extend the historical investigations on sequencing to RNA and DNA. Earlier 
scholarship has subordinated the development of sequencing to broader disciplinary 
moves. De Chadarevian, for instance, uses protein sequencing as a case study to 
investigate the emergence of molecular biology in Cambridge and the role of 
biochemists such as Sanger in this process. This paper, in contrast, will inquire when 
sequencing as a practice emerged and how it developed reciprocally affecting and 
being affected by disciplinary and professional identities.10 
 
When sequencing is understood as a practice, the activities of its inventors and users 
are stressed and placed in a wider context as particular forms of knowledge and work. 
It is then easier to link sequencing to researchers who, in solving practical problems, 
crossed disciplinary boundaries. Sequencing as a technique, on the contrary, has a 
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less active and dynamic dimensions, being understood as a tool originated and 
developing within a discipline. My historical approach will, therefore, inquire when 
scientists started sequencing molecules rather than when sequencing, as a technique, 
revolutionized molecular biology.11 
 
The history of sequencing presented here will require revisiting Sanger’s career in 
light of his scientific papers and, crucially, his laboratory notebooks, recently donated 
to the Biochemical Society, catalogued at the Wellcome Trust Archives in London 
and not previously explored by scholars. Both notebooks and papers will be 
compared with contemporary research lines and placed within the historiography of 
the “molecularization” of the life sciences.12 My paper will, consequently, contribute 
to a better understanding of how biology became molecular – by adopting and 
transforming a practice such as sequencing. It will also critically assess retrospective 
accounts of involved researchers, one of the main goals of professional history of 
science.13 
 
The first part of the paper will show that Sanger’s early work between the 1940s and 
50s was framed in biochemical analysis of proteins. Sequencing at this point lacked 
any concern with genetics and, as a practice, originated before the elucidation of the 
double helix of DNA and the emergence of molecular biology. It was not until his 
1962 move to the Laboratory of Molecular Biology – addressed in the second part of 
the paper – that Sanger began directing his techniques to RNA and DNA, and 
considering their relation to proteins as constituents of the genetic material. This shift, 
I will argue, did not create a revolutionary technique of molecular biology, but rather 
redefined a pre-existing practice according to the parameters of the new emergent 
discipline. 
 
FIGURE 1 
 
-1.Research on proteins: a new practice emerging in biochemistry (1943-62). 
 
Sanger started his career in a period of profound change at the Department of 
Biochemistry of Cambridge. Its charismatic director, Frederick G. Hopkins, retired 
and was substituted by Charles Chibnall in 1943. The broad approach to biochemistry 
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defended by Hopkins – which included genetic, comparative and embryological 
studies of metabolism – was substituted by Chibnall’s more specific interests in 
protein analysis. Sanger’s early work on insulin initially squared with Chibnall’s 
interests, but gradually developed into a distinctive practice named sequence 
determination, and directed to the identity and order of amino acids in the protein. 
 
Part 1 of this paper will show that Sanger’s early work remained within the confines 
of biochemistry. The determination of the sequence of insulin was framed in the 
dominant research line at his department, using the methods of organic chemistry to 
analyze the amino acid composition of proteins. With the completion of insulin and 
spread of sequence determination, Sanger’s practice began impacting not only 
Chibnall’s team and biochemistry, but also other groups beyond the boundaries of 
this discipline. 
 
-1.1.Chibnall, Fischer and the structural studies of proteins. 
 
The Dunn Institute of Biochemistry, the name of Cambridge’s department at Sanger’s 
arrival, was known for having been created in 1924 by Hopkins, one of the precursors 
of this discipline. Hopkins defended a “dynamic” or “general” approach to 
biochemistry, consisting in a multi-perspective study of metabolism (i.e. how 
nutrients and other inputs were processed by the cell. The research included 
comparison between the metabolisms of different species, genetic investigations of 
the regulation of the metabolic process and study of its development from embryo to 
adult. They were conducted by researchers as diverse as Ernest Baldwin, J.B.S. 
Haldane or Joseph Needham.14 
 
When Sanger started his PhD at the Institute (1940), Hopkins was advanced in years, 
many of his collaborators had left and his influence was significantly decreased. He 
was replaced in 1943 by Chibnall, plant biochemist who brought to Cambridge most 
of his team from Imperial College, London. 15  Historian of biochemistry, Robert 
Kohler, has shown how Chibnall’s arrival substituted Hopkin’s broad approach with 
“much narrower interests in plant proteins”. Chemical investigation of proteins 
became subsequently a privileged research line at the Institute, especially amino acid 
analysis, a technique of which Chibnall is considered one of the pioneers.16 
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Chibnall described this technique in a 1942 lecture. The proteins were broken into 
their constituent amino acids by different procedures and then the quantity of each 
amino acid was determined. Using this method, he had been able to determine the 
number of “aspartic acid, glutamic acid, arginine, histidine and lysine” in a number of 
proteins. These studies, Chibnall claimed, would allow the correlation of the 
“composition” of the protein with its “nutritive value” – i.e. how proteins acted in the 
body.17 
 
Chibnall placed his work within a line of research which had arisen in the mid 19th 
century and consisted in applying the methods of organic chemistry to the study of 
biological molecules. In the same lecture, he quoted Justus von Liebig, Franz 
Hofmeister and Emil Fischer as the sources which inspired his investigations. 
Historians of biochemistry have considered these German researchers among the 
pioneers in extending to biology the analytical techniques of chemistry.18 Hofmeister 
and Fischer, additionally, are also credited as the postulators of early hypotheses 
about protein structure. 
 
Both researchers, based on the chemical analysis of a large number of proteins, 
concluded in 1902 that there were recurrent patterns in their structure. Whereas 
Hofmeister established that proteins were characterized by repetitive associations of 
carboxyl and amide groups – i.e. chemical links recurring along their structure – 
Fischer postulated that they were “chains” of amino acids (ketie, in German) linked 
by “peptide bonds” between such groups. Amino acids, consequently, were 
associated in small peptide chains.19 
 
Historian Joseph Fruton has shown how up to the late 1930s, there were reasons to 
question Fischer and Hofmeister’s hypotheses. First, Fischer himself had expressed 
doubts about the validity of his peptide bonds in longer protein chains. Second, other 
researchers considered that for explaining “the specific biological and physical 
properties” of proteins other types of chemical bond were necessary giving the 
molecule a globular structure.20 There was, finally, an enduringly influential research 
line derived from the mid 19th century, colloidal chemistry, which claimed that 
proteins lacked a specific molecular structure: they were rather complex mixtures of 
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materials suspended in fluids – e.g. blood – which did not obey the laws of solution 
chemistry.21 
 
During the 1940s, the debate was being gradually solved in favor of the molecular 
structure of proteins. Chibnall, the research of other protein chemists, and the 
emergent field of physical chemistry had proven that even in long protein chains, the 
linear arrangement of discrete amino acids was the most plausible structure. 
Nevertheless, even amongst the supporters of Fischer and Hofmeister there were 
disagreements on the nature of the amino acid arrangements in the peptide chains 
characterizing proteins. 
 
-1.2.Periodical or undetermined chains? 
 
Fischer’s peptide hypothesis had different interpretations among its followers during 
the 1930s and 40s. A considerably widespread one at the time of Chibnall’s 
appointment in Cambridge was that of Max Bergmann, former collaborator of Fischer 
working at the Rockefeller Institute of New York. Bergmann was Head of the 
Institute’s Laboratory of Chemistry where he investigated protein analysis and 
synthesis. Taking a series of observations by his assistant Carl Niemann, Bergmann 
postulated in the late 30s the periodicity hypothesis, according to which protein 
chains were formed by patterns of amino acids which were repeated at regular 
intervals.22 
 
Bergmann further proposed the formula 2n X 3m, which allegedly described the total 
number of amino acids in any given protein (Bergmann and Niemann, 1938, pp. 577-
579). The powers (n and m) of 2 and 3 defined the different intervals at which the 
amino acids were, supposedly, repeated. Taking the equation, Bergman and Niemann 
proposed “a classification of the numerous individual proteins” in which their basic 
properties and structure would be mathematically estimated through variations of the 
formula 2n X 3m.23 
 
Not all researchers, however, interpreted Fischer’s theory in the same way. Among 
the most critical biochemists of the periodicity hypothesis were those based in 
Cambridge who were convinced that proteins were undetermined structures. Their 
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study, hence, required chemical analysis instead of mathematical predictions. Bill 
Pirie and Albert Neuberger, Sanger’s PhD Supervisors, were among the first in 
attacking Bergmann and Niemann during the late 1930s, also using mathematical 
arguments. In independent papers, they showed that almost every possible 
distribution and total number of amino acids in a protein may be expressed as a result 
of the formula 2n X 3m.24 
 
Chibnall also dismissed the periodicity hypothesis, but used chemical analysis instead 
of mathematical methods. In his 1942 paper, he showed that the amino acid 
composition of edestin, β-lactaglobulin, egg albumin and insulin yielded values 
contradicting Bergmann and Niemann’s formula. Based on this, he concluded that the 
protein molecule was a “system of peptide chains of varied composition” and that, for 
determining its structure, it was necessary to analyze it physically and chemically, 
rather than mathematically: 
 
"Clearly the analyst (…) can contribute but little on his own, and there is need for more co-
operation with the physical chemist and crystallographers, who are able to investigate the 
properties and structure of (…) the intact protein molecule itself. (…) Meanwhile, I think that 
those interested in proteins would be wise to regard the Bergmann-Niemann hypothesis as 
still tentative and in any case as applicable only to the component peptide chains of the 
molecule, for much of the evidence hitherto brought forward to support it has been based on 
inadequate experimental data and has demonstrated nothing more than the hypnotic power of 
numerology".25 
 
This context of critique to periodicity and preference for chemical methods framed 
Sanger’s early work on insulin during the mid and late 1940s. Departing from 
Chibnall’s amino acid analysis, he substantially modified the technique and this 
allowed him not only to determine the “composition” of proteins, but also the 
“sequence” of their amino acids along the chain.26 
 
-1.3.Determining an unpredictable sequence. 
 
Chibnall’s arrival in Cambridge coincided with the completion of Sanger’s Ph.D. 
thesis. The similarities in their personalities, both preferring the bench to the meeting 
room, resulted in trust and affinity. Chibnall asked Sanger to participate in his project 
on chemical analysis of insulin, started at Imperial College and which became the 
main line of research in his group at Cambridge. Sanger accepted the offer and was 
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incorporated to the team, but instead of just applying the amino acid analysis 
techniques, he introduced a series of variants which determined not only the number 
and nature, but also the position of the amino acids in the molecule.27 
 
Sanger’s first assigned duty within the insulin project was quantitatively estimating 
and identifying the amino acids located at the end of the molecule’s chains. For so 
doing, he devised a method combining procedures already used by other group 
members with new instruments. Among the former, he applied column 
chromatography, a technique which permitted the separation of the amino acids of a 
protein after their being cleaved from the chain. This method had been introduced in 
the early 1940s and extensively applied to amino acid analysis by Chibnall’s team, 
among other researchers.28 
 
Sanger, however, added to the method a chemical substance – dinitrofluorobenzene 
(DNFB) – suggested by Chibnall and not used before in protein analysis. DNFB 
reacted with the last amino acids of the insulin chains, dying them yellow. This 
substance allowed Sanger not only to quantify, but also to identify the amino acids, in 
line with Chibnall’s request. By applying DNFB and cleaving the insulin molecule 
with acids, he broke all the amino acids of the chains. He then separated the mixture 
of loose amino acids through column chromatography and determined, from their 
yellow color, which ones were located at the end of the chains.29 
 
The paper in which Sanger reported the results of those experiments, written in 1945, 
defined insulin as a molecule formed by “four open polypeptide chains”.30 He was, 
then, describing the protein as a series of peptide-linked amino acid chains, in line 
with Chibnall’s investigations and Fischer’s hypothesis.31 In his subsequent papers, 
published in 1949, Sanger began referring to the insulin molecule as a “sequence,”32 a 
term which despite having been used before (see next subsection) had never appeared 
in Fischer or Chibnall’s articles. Sanger’s sequences were formed by the ends of the 
insulin chains together with the neighboring amino acids, to which he directed his 
further experiments. 
 
Sanger concretely managed to identify and determine the position of the four to five 
amino acids beside the ends of the insulin chains between 1945 and 49. He achieved 
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this by introducing two innovations into his technique. Firstly, the protein was 
submitted to partial rather than complete cleavage: instead of separating the amino 
acids individually, Sanger reduced the time of acid exposure and obtained peptides, 
i.e. mini-chains of four to five amino acids. Secondly, an improved separation method 
called paper chromatography was incorporated, which involved a sheet of cellulose as 
the medium and performed the separation in two instead of one direction. The 
resulting amino acid pattern on the paper – i.e. the chromatogram – was, hence, two-
dimensional.33 
 
The new method, which Sanger named the degradation approach, consisted in 
submitting various insulin samples to partial cleavage and the resulting yellow 
peptides – DNFB labeled and at the end of the chains – to further breakages. In this 
way, he obtained a series of overlapping amino acid fragments, for instance 
phenylalanine, phenylalanine-valine and phenylalanine-valine-aspartic acid. By 
separating the fragments through chromatography and submitting them to amino acid 
analysis – as Chibnall and his group members were doing – it was possible not only 
to identify and quantify, but also to deduce the order of amino acids in the chains. 
“The increasing complexity of each of those peptides,” Sanger claimed, “suggested 
that they were all breakdown products of the same peptide chain”.34 
 
FIGURE 2  
 
Sanger referred to these amino acid peptides as sequences. The term differed from his 
1945 paper, and the use of the term chain by Fischer, Chibnall and other members of 
his group. Sanger, nevertheless, used his sequences as evidence for the protein 
structure hypothesis preferred by his Institute. In the conclusions of his 1949 papers, 
he mentioned that the investigations on insulin and comparison with the terminal 
peptides of other proteins 35  suggested that there were no rules governing their 
structure and it was, consequently, unpredictable: 
 
"Investigations of the free amino groups of a number of proteins by [this] technique (...) have 
shown that the terminal position in the protein chains may be occupied by a variety of 
different amino acids. There appears to be no principle that defines the nature of the residue 
occupying this position in different proteins and it would seem probable that this would apply 
to other positions in the molecule".36 
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Sanger’s early experiments on insulin were, therefore, framed in the perspectives and 
research interests of Chibnall’s group, but also progressively shifted towards new 
goals. On the one hand, Sanger exclusively used chemical methods to analyze the 
protein chains and suggested with his experiments that they were unpredictable, in 
line with Cambridge’s Dunn Institute views.37 On the other, in so doing he gradually 
abandoned his first duty of determining the terminal amino acids of insulin and 
directed his methods to increasingly larger sequences within the molecule. Sanger’s 
latter goals resulted in a new practice within biochemistry, identified during the 1950s 
with sequence determination. 
 
-1.4.An emerging practice. 
 
By introducing further modifications into the method, Sanger managed to apply it to 
the central parts of insulin and to determine its whole sequence between 1951 and 
55. 38  At that time, the use of the term sequence increased in Sanger’s papers. 
Whereas in previous articles this term had been either absent or combined with other 
ways of referring to the protein chains such as “free amino groups,” “terminal 
peptides” or insulin “structure”, in these new investigations the papers clearly stated 
in their titles that the object of Sanger’s research was the “amino acid sequence” of 
the molecule. Furthermore, Sanger described his activity as “to determine the 
complete amino acid sequence” of certain parts of insulin – firstly its phenylalanyl 
and then its glycil chain.39 He also began to benefit from the help of his assistants, 
biochemists Hans Tuppy and E.O. Thompson, who co-authored the papers, learnt the 
sequence determination techniques and spread them in a variety of ways during their 
further careers. 
 
FIGURE 3 
 
Sanger was not the first in using the term sequence for referring to protein structure. 
Archer Martin and Richard Synge, also biochemists educated in Cambridge, had 
raised the possibility of studying “structural sequences” in proteins during the mid 
1940s. The parallelisms between these researchers and Sanger are remarkable. Synge 
had also been based in the Dunn Institute of Biochemistry and supervised by Pirie just 
before Sanger’s arrival – mid-late 1930. Martin had started his career at an offshoot 
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of that institute, the Dunn Nutritional Laboratory. Both investigators, as Sanger, were 
devoting their research to the development of methods, in this case for the separation 
of amino acids and other biological mixtures.40 
 
The career of Sanger has significant overlaps with those of Martin and Synge, based 
from the early 1940s in the Wool Industries Research Institution in Leeds.41 There, 
Martin and Synge introduced column and paper chromatography, the main techniques 
for the experiments Sanger reported in his 1945 and 49 papers. Sanger, additionally, 
coincided with Synge in 1947 during a visit to Arne Tiselius’s laboratory in Uppsala, 
which was another major center in the development of chromatography and 
separation techniques.42 
 
Martin and Synge’s investigations, like those of Sanger, had similarities with the 
work of Chibnall’s group during the early 1940s. When they first proposed 
determining structural sequences of proteins in 1943, their separation techniques were 
directed to the “composition” of the small peptide gramicidin. The paper sought to 
chemically identify and estimate quantitatively the amino acids forming gramicidin, 
and the determination of its sequence was only stated as a long-term possibility. 
However, with the introduction of paper chromatography in 1944, Martin and Synge 
presented this new separation technique as directed to “qualitative analysis of 
proteins”. The technique’s capacities, they suggested, went beyond a simple 
quantification of amino acids. In 1947, Martin and Synge used paper chromatography 
to determine the “sequence” of gramicidin and proposed applying the technique “with 
increasing confidence for studies of the sequences of amino acids residues in peptide 
structures generally”.43 
 
Sanger had also been working on gramicidin during the 1940s, at the same time as his 
early insulin work. Despite only publishing one paper on gramicidin, the first 
volumes of his notebooks – written between 1945 and 49 – contain a number of 
experiments on this peptide scattered among those on insulin. Furthermore, prior to 
his 1949 papers – when Sanger first used the term sequence – he began referring to 
the results of paper chromatography in the notebooks as “qualitative.” All these 
parallelisms – together with the extensive quotes to Martin and Synge in Sanger’s 
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1950s papers – suggest that Sanger adopted the concept of sequence from these two 
researchers.44 
 
There were, however, differences between Sanger, and Martin and Synge’s sequence 
determination efforts. Whereas the latter used sequence determination as a means to 
test their separation techniques, Sanger made this activity the goal of his career. 
Sanger’s research objects were the sequences; the methods to determine these 
included not only separation techniques, but also other biochemical instruments. He 
was the first in making sequence determination a goal and devoting the whole efforts 
of his research to it. 
 
Sequence determination, therefore, emerged as a new practice in Britain during the 
mid and late 1940s. Martin and Synge defined it as a distinguishable activity, and 
Sanger transformed it into a clear career objective. This career objective overcame the 
quantitative amino acid analyses dominant at Cambridge’s Dunn Institute of 
Biochemistry and directed them towards a new goal through a differentiated 
methodology. 45  Nevertheless, despite these peculiarities, Sanger’s insulin method 
remained strongly framed in the research tradition represented by Fischer and 
embodied in Chibnall’s group. Sequence determination, initially, incorporated the 
working procedures of analytical and synthetic organic chemistry. 
 
-1.5.A purely (bio)chemical activity. 
  
Bergmann, Chibnall, Martin and Synge, and Sanger, despite their discrepancies, 
shared a working tradition marked by the application of the instruments of chemistry 
to biological molecules. This tradition had been established, among others, by 
Fischer, a chemist by background who between the late 19th and early 20th century 
became increasingly interested in proteins and applied to them his techniques. The 
application of chemistry to biology and proteins was progressively named 
biochemistry – or more concretely protein chemistry – being the research 
environment in which Sanger developed his work. 
 
In a 1907 lecture, Fischer reflected on the convergence of chemistry and biology. He 
considered it natural and quoted classical chemists – among them von Liebig – as the 
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precursors of this confluence.46 At the beginning of the 20th century, Fischer claimed, 
chemistry was equipped with a “powerful armory of analytical and synthetical 
weapons” which would bring a “clearer insight” into the “processes which constitute 
animal and vegetable life”. These methods, developed in their modern version 
between the late 18th and 19th centuries, were respectively characterized by breaking 
molecules into fragments – analytical – and assembling such fragments into new 
compounds – synthetic.47 
 
Fischer had pioneered the application of these techniques to proteins, analyzing and 
synthesizing a large number of compounds. He named his analytical techniques 
“degradation methods” and directed them to the “composition” of the molecules – 
just as Sanger and Chibnall would do.48 In his 1907 lecture, Fischer described his 
experiments as follows: 
 
“The conclusions which have been drawn in other cases from the results obtained by the 
dissection of compounds have been too frequently confirmed by their synthesis. It is now 
possible to make this claim on behalf of the proteins, as it has been found to be possible, by a 
process the reverse of hydrolysis [breakage of the chains] to associate amino acids in such a 
manner that substances are produced which (…) resemble proteins. I have termed these 
synthetic products polypeptides”.49 
 
Fischer’s analytical and synthetic tradition was followed by Bergmann and Chibnall. 
The former, after working as a close associate of Fischer, created a research school at 
the Rockefeller Institute, engaged since the 1930s in the synthesis and structural 
analysis of proteins. Chibnall, contemporaneously, formed a group devoted to the 
study of the amino acid composition of insulin and other proteins, moving it to 
Cambridge in the early 1940s.50 
 
In his history of biochemistry, Kohler has identified “three distinct styles” 
characterizing the diversity of this discipline during the first decades of the 20th 
century: clinical, biological and bioorganic-biophysical.51 Fischer’s line of research 
and its continuation by Bergmann and Chibnall corresponded with the third one 
which was strongly oriented towards analytical and synthetic chemistry. None of 
these researchers showed medical concerns or any interest in the biology (e.g. the 
metabolic processes) of living organisms. 
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Chibnall’s 1943 move to Cambridge may, hence, be interpreted as a shift from a 
biological to a bioorganic and biophysical style at the Dunn Institute of Biochemistry. 
This researcher lacked the broad approach to metabolism of Hopkins and as new 
Head of the Institute favored the application of the analytical techniques of chemistry 
to proteins.52 His model was, however, short-lived, since in 1949 Chibnall resigned 
due to the large administrative duties involved in the position and the Institute turned 
to a more medical orientation.53 
 
Sanger’s sequence determination efforts were decisively shaped by the growth of 
protein chemistry at the Institute and remained an important line of research after 
Chibnall’s tenure.54 The degradation procedure was based on the breakage of insulin 
into fragments and its further reconstruction through identifying overlaps. In so 
doing, Sanger was applying the cleaving, separation and quantification methods of 
analytical chemistry already used by the other members of Chibnall’s group. He was 
also employing, though not experimentally, the strategy of synthetic chemistry in 
attempting to reconstruct the original molecule from the fragments’ overlaps. 
 
Sequence determination, as a distinctive practice, also added specific features to 
Cambridge’s protein chemistry. By incorporating new instruments to amino acid 
analysis – DNFB and paper chromatography – Sanger gave a new qualitative 
dimension to this method, able to yield since then the sequence and not only the 
composition of insulin. He also created, with Martin and Synge, the concept of 
sequence and the aim of achieving it through the development of techniques. Both the 
concept of sequence and the aim of determining it became especially pervasive during 
the 1950s and increasingly spread among the biochemical community. 
 
-1.6.Spread and convergence with molecular biology. 
 
The progressive completion of insulin (1951-55) and the award of the first Nobel 
Prize to Sanger (1959) made sequence determination expand in protein research. 
During the 1950s and 60s, an increasing number of biochemists either adopted the 
technique or developed alternative sequence determination methods. In both cases, 
researchers equally assimilated the working principles Sanger’s technique embodied: 
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their use of sequence determination was based on the instruments and strategic 
approaches of analytical and synthetic chemistry. 
 
One of the first investigators in devising sequence determination techniques after 
Sanger was Pehr Edman, a Swedish biochemist based in the University of Lund. His 
method, developed in 1950, also started with the cleavage of the protein, but instead 
of acids or enzymes, Edman employed a chemical substance able to cut the last amino 
acid of the chain. By successively applying this substance and submitting the cleaved 
amino acid to paper chromatography, Edman’s technique could determine sequences 
unit per unit in the correct order. This procedure was, consequently, also inspired by 
the “degradation” of the protein and the term was recurrently used in Edman’s 
paper.55 
 
Edman’s technique – rather than Sanger’s – was adopted as the basis for the 
automation of sequence determination. The process started in the late 1950s, with the 
Rockefeller Institute researchers William Stein and Stanford Moore designing an 
apparatus which automated amino acid analysis, i.e. the identification and 
quantification of the protein breakage products after being separated through 
chromatography. Stein and Moore’s strategy, described as “subtractive,” consisted in 
successively cutting the terminal amino acids of the protein by Edman’s technique 
and checking, after each cleavage, which unit was missing through the automatic 
analyzer. It was, again, based on the degradation of the molecule and the activity 
which was automated – amino acid analysis – was exactly the same Chibnall’s group 
had been performing in its investigations of protein composition.56 
 
At the same time Stein and Moore were automating amino acid analysis, Sanger was 
seeking techniques for avoiding this step in his protein methods. Amino acid analysis 
required applying a series of reagents to the chromatogram, in order to make the 
protein units visible after separation. The spots were then identified and quantified. 
Sanger considered this process “time consuming and tedious,” and after the 
determination of insulin (1955) sought means to skip it and to deduce the sequence 
directly from the chromatogram or alternative separation surface.57 
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His main strategy, developed between the late 1950s and early 60s, was to label the 
protein fragments and amino acids with radioactive substances. After separation, 
Sanger photographed the chromatogram or alternative medium, so that the 
radioactively labeled fragments or amino acids appeared as dark bands. The sequence 
could, in principle, be deduced by measuring the position of the spots in the picture, 
called a protein fingerprint.58 
 
FIGURE 4 
 
Radioactive labeling had been introduced to Sanger by Chris Anfinsen, a United 
States biochemist who had been visiting the department in 1954.59 The use of this 
technique dates back to the 30s in the fields of physiology, nuclear medicine and 
various biological disciplines. During the 50s, radioactive labeling was applied in the 
Hershey-Chase experiment and that of Matthew Meselson and Franklin Stahl, which 
combining biochemistry, bacteriology and genetics respectively showed that DNA is 
the genetic material as well as the replication mechanism of this molecule.60 Sanger 
was, thus, using a technique bridging a variety of biological disciplines – including 
the then emerging molecular biology – for eliminating amino acid analysis, an 
important chemical step in sequence determination. 
 
Another research line opened by Sanger in the late 1950s aimed to deduce the 
functioning of insulin from its recently determined sequence. He did it by comparing 
sequences of different species – e.g. pig and sheep – and studying previously 
radioactively labeled active centers of enzymes – i.e. proteins involved in the 
catalysis of chemical reactions.61 The interest in comparing and the postulation of a 
linear relationship between molecular structure and function had been present since 
the foundation of the Dunn Institute and reinforced by Chibnall’s protein analysis 
program. Historians of biology Sage Ross and Bruno Strasser have shown – in still 
ongoing investigations – that this straight view of the structure-function connection 
was characteristic of comparative biochemistry, a research tradition present at the 
Institute since Hopkins’s time, in the late 1920s and 30s. Baldwin, its main 
representative, had been Sanger’s undergraduate tutor and an important influence on 
his further career in biochemistry.62 
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The hypothesis of a straight connection between molecular structure and function was 
also emerging, throughout the 1950s, in biophysics. This discipline, articulated 
around the technique of x-ray crystallography (see notes 7, 20 and 29), had gained 
momentum with the elucidation of the double helix of DNA (1953) which led some 
researchers to focus their experiments on this molecule with the expectation of 
deducing the mechanisms of gene functioning. Philosopher of biology Sahotra Sarkar 
has characterized this hypothesis as reductionism, showing that it shaped the history 
of the emergent discipline of molecular biology. During the late 50s and 60s, an 
increasing number of biophysicists declared themselves the founders of molecular 
biology and built their further investigations on this DNA-centered scheme.63 
 
Cambridge was also an important center for these converted biophysicists. Since the 
late 1950s, Sanger maintained increasingly intense contacts with a group of 
crystallographers studying biomolecular structures at the Cambridge-based Cavendish 
Laboratory. None of Sanger’s post-insulin research lines had led to visible results at 
that time. 64  The apparent stagnation of Sanger’s protein work, together with the 
growing contacts with the Cavendish researchers, led him to start a new stage in his 
career by moving, in 1962, from the Dunn Institute to a new molecular biology center 
and applying his sequence determination techniques to RNA and DNA. 
 
Sanger’s move triggered a major reconfiguration of sequence determination as a 
practice. It consolidated the shift witnessed since the late 1950s and redefined his 
techniques in terms of the emergent molecular biology. This redefinition will be 
analyzed in the following section, which will further challenge accounts explaining 
Sanger’s career exclusively in terms of technological progress and the success of 
molecular biology. The investigation so far conducted has initially challenged such 
arguments by showing that Sanger’s institutional and professional environment was 
also crucial in providing 1) a line of research on the chemical analysis and synthesis 
of proteins epitomized by Fischer and developed by Chibnall’s group; 2) already 
available analytical methods for amino acid analysis combined by Sanger with other 
instruments in the development of his techniques; 3) an aim of determining the 
sequence of insulin which led Sanger to innovatively combine the available 
instruments and to the emergence of sequence determination as a practice initially 
framed in biochemistry. 
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-2.Research on nucleic acids: from chemical degradation to biological replication 
(1962-77). 
 
The impact of Sanger’s determination of insulin and his subsequent Nobel Prize 
(1955 and 59, respectively) made researchers all around the world follow his work. 
Especially active in this was the Cavendish Laboratory, a center in Cambridge which 
since the late 1940s had shifted from physics to host an expanding group of 
researchers studying the “molecular structure of biological systems,” as well as other 
related problems.65 Francis Crick, Sydney Brenner and other Cavendish scientists saw 
Sanger’s techniques as especially suitable for their investigations on protein synthesis 
or, as they also called it, the problem of the genetic code: how DNA specifies the 
structure of proteins. They approached Sanger in the late 1950s and persuaded him to 
move to a new center, the Laboratory of Molecular Biology (LMB), which was being 
specifically built to combine the Cavendish biological group with other researchers 
investigating related problems. After the move, Sanger began applying his techniques 
to RNA (1960s) and then to DNA (1970s). 
 
In all his retrospective accounts, Sanger has acknowledged the role of the Cavendish 
biologists in his move to the LMB. However, he has argued that these contacts “did 
not achieve the experimental level” and that his career remained mainly shaped by the 
“availability” of sequence determination instruments. 66  Part 2 of this paper will 
challenge this interpretation and show how the new research environment of the LMB 
affected Sanger’s techniques, especially in their transition from RNA to DNA. Since 
the 1960s, I will argue, sequence determination gradually shifted from the 
instruments, problems and strategic approach of chemistry to those of the emerging 
discipline of molecular biology. This transition, however, was not one-directional, as 
autobiographical and some historical accounts of molecular biology suggest. In its 
journey, sequence determination as a practice also had an impact on the way of 
conducting molecular and other forms of biology.67 
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-2.1.The move to a new center. 
 
Sanger’s interactions with the biological group at the Cavendish Laboratory – named 
Unit for the Study of Molecular Structure of Biological Systems – have been studied 
in detail by Soraya de Chadarevian and reviewed in autobiographies by the involved 
researchers.68 These interactions started in the late 1940s and were especially intense 
from 1955 onwards. At that time, Sanger had already gained scientific prestige, was 
introducing radioactive labeling into his techniques and attempting to determine the 
properties of insulin from its sequence. Both radioactive labeling and the hypothesis 
of there being a connection between the structure and function of biological 
molecules were also important in biophysics and molecular biology, the nascent field 
that the Cavendish group was promoting at that time.69 
 
The Cavendish scientists were mainly physicists who had shifted to biological 
problems after World War II. They were applying to biological molecules – namely 
proteins – the technique of x-ray crystallography, in order to determine their three-
dimensional structure. The strong orientation of this institution towards physics had 
prevented Sanger – especially antipathetic towards this discipline (see note 32) – to 
establish consistent links with it, despite his research interests being apparently close. 
Nevertheless, the elucidation of the double helix of DNA (1953) and the increasing 
attraction of biochemists towards this molecule transformed the situation in the mid-
late 50s.70 
 
A key figure in this transformation was Francis Crick. Physicist and crystallographer 
by background, he had cooperated with James Watson – a bright young US researcher 
visiting the Cavendish – in the elucidation of the double helix, reported in two epoch-
making papers in 1953. At that time, Crick was already aware of Sanger’s techniques 
and used the successively published results on insulin as evidence for the formulation 
of the sequence hypothesis. The hypothesis stated that given the complexity of 
protein structure – as Sanger had demonstrated in insulin – only an equivalently 
intricate molecule as DNA could generate it. This led Crick to postulate that the 
sequence of bases in DNA determined the sequence of amino acids in proteins.71 
 
FIGURE 5 
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Despite the sequence hypothesis not being published until 1958 in a paper devoted to 
“protein synthesis”, it inspired Crick’s work on the genetic code from the mid 1950s. 
In collaboration with another Cavendish researcher, Sydney Brenner, he investigated 
how the DNA molecule, in its expression, determined a particular sequence for 
proteins. During the late 50s, Crick and Brenner produced a series of mutations in 
simple organisms – bacteriophage viruses – and studied how their altered sequences 
of DNA affected the formation of proteins.72 
 
De Chadarevian has shown how Brenner and Crick soon realized that Sanger’s 
techniques would be extremely useful for matching concrete mutations in the DNA of 
the viruses with changes in the amino acid sequence of the resulting proteins. This led 
to contact and then an informal cooperation between Sanger and Brenner, in which 
the former determined the sequence of the proteins produced by the mutant viruses 
obtained by Brenner. A more formalized and productive association was that of 
Sanger with Vernon Ingram, a member of Crick’s group investigating sickle-cell 
anemia. Ingram used Sanger’s late protein techniques to identify the alteration in the 
amino acid sequence of hemoglobin causing the disease in 1956.73 
 
The potential of these collaborations made Crick and Brenner continually attempt to 
attract Sanger to the Cavendish Laboratory from the mid 1950s. They wanted him to 
keep applying his protein techniques to the genetic code and to begin developing 
methods for sequence determination of RNA and DNA. The efforts of both 
researchers intensified when at the end of the decade the Medical Research Council, a 
body of the British Government funding biomedical sciences, decided to establish a 
new center, the LMB, in which the Cavendish group would share building with other 
biologists, being Sanger an essential incorporation.74 The biological nature of this 
institution overcame Sanger’s past reticence towards physics and made him accept 
the offer, moving to the LMB in 1962, when it opened. 
 
Before the move, Brenner and Crick organized two seminar sessions in the Golden 
Helix – residence of the latter – where they taught the fundamentals of molecular 
biology to Sanger and the members of his group, also due to migrate. The lectures 
included the basic structure of DNA, its relation to RNA and proteins in the genetic 
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code, and, crucially, the mechanism of cell replication. Sanger and Crick’s 
recollection of this period differs in their retrospective accounts: whereas the former 
seems to have forgotten the seminars and claims to have acquired all his background 
on nucleic acids from another LMB member, John Smith, Crick considers the Golden 
Helix lectures as a key element in Sanger’s move.75 This apparently unimportant 
divergence reflects Sanger and Crick’s different view of the emergence of molecular 
biology. 
 
-2.2.Molecular biology and Sanger’s professional identity. 
 
Sanger’s move to a molecular biology center and introduction into this emerging field 
did not prevent him from considering his career as fully integrated in biochemistry. In 
his retrospective accounts, he has understood his research as invariably “involved in 
the same project” – sequence determination – which survived institutional moves and 
other environmental changes. When commenting on the effects of the move, Sanger 
refers to the “larger space and facilities” of the LMB, without seeing significant 
changes in his work. The LMB, according to Sanger, was named Laboratory of 
Molecular Biology because “there was already a department of biochemistry in 
Cambridge.” Sanger’s lack of distinction between both disciplines is confirmed when 
he refers to Crick as a “theoretical biochemist”.76 
 
Sanger’s account contrasts with de Chadarevian’s study of the foundation of the 
LMB. For de Chadarevian, Sanger’s move was a key episode in the emergence of 
molecular biology in Cambridge, marked by the “alliance of protein 
crystallographers, molecular geneticists and protein chemists.” This convergence 
required “institutional and disciplinary negotiations,” as shown by Sanger’s 
collaboration with Crick, Ingram and Brenner, together with the opening of the LMB, 
specifically built to gather these scientists77. De Chadarevian, hence, argues that the 
history of Sanger at the LMB is not one of a biochemist preserving his identity within 
molecular biology, but of a biochemist contributing, with researchers from other 
fields, towards the emergence of a new discipline. 
 
However, in the accounts of that emergence, Crick and Brenner’s views have 
prevailed over those of Sanger. The Cavendish researchers have propagated the idea 
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that Sanger invented the techniques, but they saw “the problems to which those 
techniques could be usefully applied”. This interpretation, indirectly supported by 
Sanger’s retrospective accounts, squares with the dominant picture of Sanger as a 
pure technologist applying his instruments to the theories formulated by leading 
molecular biologists.78 It is also a unidirectional account, in which the effects of the 
interactions between Crick, Brenner and Sanger are seen as having operated in only 
one way, exporting a series of inert techniques to a dynamic new field. Crick and 
Brenner’s personalities – eloquent and charismatic, in contrast with Sanger’s shyness 
– have reinforced the dominance of their account.79 
 
This points towards a more general problem in the historiography of 20th century life 
sciences: the pervasiveness of the retrospective accounts of molecular biologists. The 
prestige and perceived revolutionary nature of this discipline has led to the 
proliferation of autobiographies in which prominent molecular biologists offer their 
interpretation of the development of the field. These accounts, influential among the 
lay public and in contemporary STS research alike, have shaped the perception of 
biology after 1953 as dominated by the “revolutions” around the DNA molecule.80 
Historians have partially mitigated this effect by placing molecular biology within the 
context of the development of post-World War II life sciences. However, as de 
Chadarevian and Harmke Kamminga have argued, some scholarship on 
“molecularization” has identified the emergence of a molecular vision of life with the 
rise of molecular biology between the 1950s and 70s. This literature raises a 
unidirectional model of interaction in which all the biological disciplines were 
transformed according to the parameters of molecular biology.81 
 
Sanger’s early career shows that the phenomenon of molecularization cannot be 
solely explained in the development of molecular biology. Whilst still within the 
working parameters of biochemistry in the 1950s, he incorporated instruments and 
strategies which approached sequence determination to molecular biology. 
Radioactive labeling and the belief in a straight structure-function relationship 
bridged sequence determination as a practice and the interests of the Cavendish 
biophysicists, later self-declared molecular biologists. Furthermore, Ingram’s use of 
fingerprinting techniques showed Sanger the connection between protein sequence 
alterations and a genetic disease such as sickle-cell anemia. Another key factor in 
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Sanger’s introduction into the realm of molecular biology was his interest in protein 
synthesis since the late 1950s. 
 
-2.3.Protein synthesis and the transition to nucleic acids. 
 
An analysis of Sanger’s laboratory notebooks shows that his transition from protein to 
nucleic acid sequence determination was gradual and not just fostered by a single 
event. His latest insulin volumes, written between 1960 and 62, show that his 
experiments on RNA started while still at the Dunn Institute, in parallel with those on 
radioactive labeling and comparison of protein sequences. At that time, Sanger 
became interested in the problem of protein synthesis and incorporation of amino 
acids into the protein by transfer RNA. In his RNA books, written after his move to 
the LMB, the experiments on proteins decreased, but the engagement with synthesis 
remained to inform Sanger’s work even during the 70s, when he shifted to DNA 
sequence determination. Some of his LMB assistants – e.g. Ieuan Harris and Brian 
Hartley – kept working on proteins in the 60s and 70s.82 
 
FIGURE 6 
 
Protein synthesis had been a concern of biochemists since the first decades of the 20th 
century, including researchers at the Dunn Institute especially before Chibnall’s 
arrival. In the 1950s, it also became a main interest of molecular biologists, for it 
epitomized the relationship between DNA, RNA and proteins. Historian Bruno 
Strasser has shown how during the late 40s and 50s there were alternative models of 
protein synthesis proposed by both biochemists and molecular biologists. Hans-Jörg 
Rheinberger has argued that during this same period, protein synthesis as an 
“experimental system” gradually shifted from biochemistry to be used by an 
increasing number of self-declared molecular biologists83. Protein synthesis was a 
concern of both Sanger and Crick between the late 50s and early 60s. However, 
whereas the latter postulated it as a one-directional transfer of information from 
DNA, RNA and then proteins – the celebrated central dogma of molecular biology  –
84 Sanger regarded it rather as a means to link his protein work with that which he had 
begun on nucleic acids. 
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Sanger’s engagement in protein synthesis since the late 50s shows that his contacts 
with Crick and Brenner, as well as Ingram’s experiments, were important in 
interesting him in the concerns of molecular biology. However, the previous tradition 
on protein synthesis in biochemistry, together with the way Sanger introduced it in his 
notebooks – as well as radioactive labeling and sequence comparison – reflects a 
gradual incorporation rather than a dramatic shift. Sanger assumed protein synthesis 
for practical reasons, to give coherence to his work and not as a disciplinary dogma. 
This suggests that he was not converted to molecular biology in a single non-critical 
step – e.g. the Golden Helix seminars or his move to the LMB. Sanger rather 
progressively incorporated tools and strategies of molecular biology to facilitate his 
transition to nucleic acids. 
 
Sanger’s move to RNA and DNA sequence determination, hence, endorses de 
Chadarevian and Kamminga’s model of molecularization: two-directional and relying 
on particular research strategies. Both historians have argued that the 
molecularization of the life sciences between the 1950s and 60s depended not only on 
molecular biology, but on previous research traditions which were equally centered in 
a molecular explanation of biological phenomena.85 In this regard, Sanger’s contacts 
and move to the LMB transformed sequence determination from its previous 
biochemical identity, but sequence determination as a practice also impacted the way 
in which molecular biology was conducted. Sanger’s techniques, consequently, had a 
meaning of their own and transformed the problems to which Brenner and Crick 
applied them. In order to develop this argument, I will first review the changes Sanger 
introduced into his techniques while at the LMB, in order to explore their historical 
meaning. 
 
-2.4.The development of a new technique. 
 
Sanger’s first task at the LMB was expanding his already initiated experiments on 
RNA sequence determination. He did so with a similar method to that he used in his 
late insulin work. The RNA fragments were degraded with enzymes and radioactively 
labeled, so that the sequence could be deduced from the separation surface – also 
two-dimensional – by detecting overlaps.86 Sequence determination, hence, remained 
mainly within the parameters of analytical and synthetic chemistry. 
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With this technique, Sanger determined the sequence of a number of short transfer 
and ribosomal RNAs during the 1960s and early 70s. Sanger’s investigations attracted 
increasing interest and contacts from molecular biologists, not only at Crick and 
Brenner’s laboratory, but also outside the LMB. During the second half of the 1960s 
and 70s, a number of molecular biology institutions devoted considerable efforts to 
determine longer RNA sequences.87 Sanger’s assistants at that time, equally, had less 
specific biochemical profiles: Bart Barrell, joining the laboratory in the early 1960s, 
was educated to A-level without a university background, and George Brownlee, 
appointed at the same time, came from a biological degree in Cambrdige. 
 
When Sanger attempted to apply the degradation procedure to DNA, he found that it 
was unsuitable to this molecule, due to DNA being longer than proteins and RNA. 
This forced him to create an “entirely new approach” to sequence determination, 
called the copying procedure and based on duplicating rather than degrading the 
molecule.  In this method, developed during the late 1960s and 70s, the DNA was no 
longer successively broken, but replicated with an enzyme (polymerase) which, in the 
presence of a series of loose nucleotides, progressively added complementary bases to 
the DNA to be determined – i.e. the template DNA.88 
 
By different means – the so-called plus and minus, and dideoxy methods – Sanger 
managed to stop the polymerase additions at each of the four nucleotides. Since 
polymerase acted simultaneously in various DNA samples, the result was a series of 
overlapping fragments in which the last unit (adenine, cytosine, guanine or thymine) 
was known. If the fragments were separated by size, the sequence could be deduced 
by analyzing the ends of the fragments – progressively bigger – on the resulting 
separation surface.89 
 
FIGURE 7A 
 
The copying procedure incorporated gel electrophoresis, a different separation 
technique from chromatography. By placing the DNA fragments on a slippery surface 
– a porous gel – and applying an electric charge, gel electrophoresis was able to 
displace them according to size with remarkable precision (Thurtle, 1998). The 
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separation gel electrophoresis produced in DNA was different from chromatography. 
Sanger divided the gel into four lanes and placed the fragments respectively ending in 
adenine, cytosine, guanine and thymine in each of them. When the electric charge 
was applied, the fragments migrated vertically from top to bottom. The separation, 
hence, was one-dimensional instead of two-dimensional, with the fragments ending in 
each nucleotide vertically aligned and horizontally separated into four lanes.90 
 
As a result of the fragments being radioactively labeled and having a ladder-like 
overlapping nature, the sequence could be deduced by scanning a picture of the gel – 
called autoradiograph – with the eye. The researcher began at the bottom of the 
picture, checking for a dark band – the product of radioactivity – in the four lanes. By 
progressively moving up and repeating the operation, it was possible to determine the 
sequence. 
 
FIGURE 7B 
 
-2.5.The insufficiency of a technological explanation. 
 
Sanger has persistently claimed that his shift from a degradation to a copying 
procedure was mainly due to the different “availability of technologies” between the 
1960s and 70s. Both in his autobiographical account and further interviews, he has 
stressed the role of a series of technical instruments which, allegedly, became 
available at the time he developed his DNA methods. These instruments, namely 
polymerase and gel electrophoresis, were, according to Sanger, the crucial factors in 
his change of approach once he realized that the degradation procedure was 
unsuitable for DNA.91 
 
Sanger’s account is, to a large extent, based on his self-definition as a “technologist,” 
i.e. a scientist concerned with the “development of methods” rather than with the 
formulation of hypotheses. 92  However, a closer look at his transition to copying 
suggests that this account may have been created to fit with Sanger’s self-portrayal. 
The main evidence for this is Sanger’s hesitation about this matter in a passage of his 
autobiographical paper. In it, he admits that the account may have been 
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retrospectively constructed, since he does not have sound enough memories of the 
time: 
 
“[The] new approach to DNA sequencing was I think the best idea I have ever had (…), so I 
have attempted to describe its development in some detail, but on reading it through I must 
confess that I am by no means certain that it really did happen like that. I certainly do not 
remember having the idea, whereas I do remember doing some preliminary experiments and 
discussing it with [my assistants] Alan Coulson and John Donelson. I have a feeling that the 
above account [entirely technological] may have originated to some extent from my attempts 
to explain the method in a simple way when giving lectures, and that subsequent frequent 
repetition resulted in its being established as part of my official, but perhaps not actual, 
memory”.93 
 
Sanger’s account may, thus, be a simplification in light of the further success of the 
copying procedure. It presupposes a Eureka moment – having the copying idea – and 
a single shift in which the method was developed by adopting the available 
technologies. The technological explanation, therefore, squares with Crick and 
Brenner’s view of Sanger entering into molecular biology and changing his sequence 
determination procedures in one simple step. Nevertheless, the late 1960s and 70s 
record of experiments shows that they were conducted in a radically different fashion. 
 
Sanger’s account, firstly, considers only his successful experiments. However, his 
laboratory notebooks show that Sanger’s failed attempts and dead ends were at least 
as significant as his viable procedures which did not develop in a linear fashion.94 
The experiments are frequently accompanied by comments such as “where everything 
goes?,”, “don’t seem to make much sense” or “look ghostly”, referring to the 
chromatograms or autoradiographs. 95  These comments and parallel alternative 
attempts became especially abundant around 1966, when Sanger and his assistants 
first directed their techniques towards DNA. 
 
The team first aimed to create hybrid templates of RNA and DNA, adopting 
polymerase since, at least, 1970. Its intention then was not to pursue a copying 
procedure, but to create shorter DNA fragments in order to apply the degradation 
strategy. These polymerase-derived fragments were submitted to two and then one-
dimensional electrophoresis by John Donelson, a US biochemist who pioneered the 
application of gel electrophoresis at the LMB during a postdoctoral stay. 
Nevertheless, his goal was to reconstruct the sequence from the overlaps rather than 
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to scan it visually, as in the copying approach. Sanger and his assistants published a 
number of papers with small DNA sequences elucidated through these techniques.96 
 
Around 1973, Sanger reported in his notebooks an attempt consisting in “copying 
with all four” DNA nucleotides. Shortly afterwards, he described a “fairly ambitious 
experiment” which incorporated the main features of the copying procedure. The 
method required a significant number of refinements in subsequent experiments and 
the expressions “plus” and “minus approach” gradually gained significance. Also 
gradually, the experiment reports acquired a homogenous format and a model DNA 
sequence – that of bacteriophage virus ØX-174 –was determined using the new 
copying approach.97 
 
FIGURE 8 
 
Sanger’s copying approach, therefore, emerged gradually rather than as a product of a 
Eureka moment. As with his transition from protein to nucleic acids, it was a 
consequence of practical decisions while developing his sequence determination 
techniques and not an abrupt shift towards molecular biology. Sanger’s career, in this 
regard, presents the features of what F.L. Holmes has called “investigative pathway,” 
a research trajectory which does not develop in a linear fashion, but shows an overall 
continuity. 98  What was important in Sanger’s investigative pathway was not the 
technologies or their availability, but rather the reasons for his combining them in the 
copying approach. 
 
This is especially true since the same technologies were being simultaneously used 
during the 1960s in sequence determination and other structural analyses of nucleic 
acids. Researchers in the United States and Europe were applying polymerase and 
gels to RNA and DNA at the same time Sanger was developing his copying approach. 
This contemporary use, apart from further questioning the availability of technologies 
argument, shows that sequence determination was becoming a widespread practice, 
with multiple ramifications and approaches. Its study, thus, requires focusing on all 
the historical attempts rather than on retrospectively big names, such as Sanger.99 
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Polymerase had been isolated in 1956 and applied to RNA and DNA sequence 
determination in the subsequent decade. 100  Molecular biologists at Stanford and 
Cornell University A.D. Kaiser and Ray Wu used it in the late 1960s to determine the 
sequence of the sticky ends of the bacteriophage λ, two short single-stranded DNA 
fragments at the ends of its genome. One year later, the Zurich-based researcher Carl 
Weissmann applied a variation of the enzyme to the RNA virus Qβ. This enzyme, 
RNA polymerase, was able to duplicate ribonucleic acids.101 
 
Kaiser, Wu and Weismann were, thus, creating an approach to sequence 
determination based on reproducing a biological process – RNA and DNA replication 
with polymerase – rather than degrading and reconstructing the molecule. This 
approach was, however, combined with other non-biological instruments to deduce 
the sequences: Kaiser and Wu used statistical analyses to measure the incorporation 
rates of the different nucleotides by polymerase, whereas Weissmain applied the two-
dimensional chemical separation. 102 In the case of Sanger, the transition towards 
biology would be more significant. 
 
A key element for Sanger’s transition was the adoption at the LMB of gel 
electrophoresis as the separation method. This instrument had been introduced by 
Tiselius in the 1930s and extensively applied to proteins.103 During the 60s, a number 
of researchers, largely with medical motivations, used gel electrophoresis for 
qualitative and quantitative analyses of nucleic acids. They did so by dividing the gel 
into lanes and running a different RNA or DNA molecule – previously radioactively 
labeled – in each lane. By comparing their different mobility, they estimated the 
“species” of nucleic acid molecule in the lanes.104 
 
Sanger had sporadically used electrophoresis in different media – especially paper – 
during the development of his protein and RNA techniques. However, it was not 
applied systematically in his laboratory until the first attempts to determine DNA 
sequences in the late 1960s. Donelson – who had been a student of Wu – was the first 
to apply electrophoresis at the LMB, but mainly from within the degradation 
approach. With the advent of the copying procedure, Sanger introduced a key 
modification in the handling of the gel: instead of running various DNA molecules, 
one in each lane, he produced, from a single DNA template, fragments ending in each 
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of the four nucleotides and used the lanes to separate the nucleotides rather than the 
molecules. This way, the lanes were not representative of a species of DNA, but of a 
group of fragments ending, respectively, in adenine, cytosine, guanine and 
thymine.105 
 
FIGURE 9 
  
Gel electrophoresis and polymerase were, thus, differently applied to sequence 
determination by Sanger rather than introduced for the first time into this practice. 
Both instruments had a recognizable tradition of use in sequence determination and 
other biological areas when Sanger incorporated them to his DNA copying procedure. 
This suggests that, rather than their availability, the most significant factor was their 
being combined innovatively at the LMB in a new approach to sequence 
determination. 
 
This approach, additionally, started to be referred to as sequencing by Sanger and the 
increasing number of researchers using this practice at the LMB and abroad. The term 
first emerged in Sanger’s early 1970s laboratory notebooks and was used in the paper 
where he described the plus and minus method, published in 1975. It was then 
incorporated into the title of the article “DNA sequencing with chain terminating 
inhibitors,” where Sanger described the dideoxy technique (1977).106 The term spread 
among molecular biologists during the 80s and became the dominant way of 
describing sequence determination. Sequencing, as well as being called by a different 
name, had significantly changed its identity when compared with Sanger’s previous 
degradation approach. 
 
-2.6.Sequencing and its move towards biology. 
 
The insufficiency of a technological explanation raises the question of what made 
Sanger combine polymerase and gel electrophoresis in the way that resulted in his 
DNA copying approach. A tentative answer is the novel research environment of the 
LMB, where Sanger was immersed since 1962 after starting introducing into his work 
the problems of DNA and its relation to RNA and proteins. If the dominance of 
chemical analysis and synthesis at the Dunn Institute had shaped Sanger’s 
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degradation procedure, the new research problems, methodologies and instruments 
used at the LMB may have created the context which, beyond the technologies, 
affected the emergence of copying. 
 
This context has been analyzed in detail by de Chadarevian, who defines the LMB as 
a “federative structure” marked by three independent groups. The first two had been 
operative at the Cavendish Laboratory and respectively focused on x-ray 
crystallography and the emergent discipline of molecular genetics. Whereas the 
crystallography group – leaded by Perutz and Kendrew – had traditionally focused on 
proteins and maintained this interest at the LMB, the molecular geneticists – headed 
by Crick and Brenner – increasingly focused on DNA and its connection to RNA and 
proteins. The third group, led by Sanger, entered the laboratory in 1962 and 
simultaneously developed protein and nucleic acid sequencing techniques. 107 
Nevertheless, Sanger increasingly focused on the latter and left proteins to his 
assistants. 
 
During the early and mid 1960s, coinciding with the foundation of the LMB and 
Sanger’s move, the molecular genetics group was shifting towards new research areas 
after the elucidation of the genetic code mechanism in 1961.108 One of these was cell 
division, pursued by Brenner in cooperation with François Jacob, another emergent 
molecular biologist at the Pasteur Institute in Paris.109 The entrance of Brenner and 
Jacob into this problem, according to the former, led to a shift in the investigation of 
cell division from the perspective of biochemistry to that of molecular biology. 
 
Brenner supports this claim by pointing to a change of the methods they used to 
investigate how DNA directs the copy of the cell by replicating itself. Shortly after 
the isolation of polymerase in the mid 1950s, a number of biochemists had put this 
enzyme and DNA into a test tube, with the aim of analyzing the process. Brenner and 
Jacob, rather than artificially reproducing the event, sought to understand how it 
worked in a living organism which they had already used, the bacterium E. coli.110 In 
their investigations, which began in 1962, they also applied radioactive labeling and a 
strategy Brenner had used in his 1950s genetic code research: producing mutations in 
E. coli’s DNA and analyzing their effects in the replication and cell division 
processes.111 
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As these experiments were being conducted (1962-63), Sanger was developing his 
RNA technique through a procedure which was still framed in chemical degradation. 
His work was closely followed by Brenner, who maintained regular exchanges with 
Sanger and used RNA sequence determination in his cell division experiments. 
Brenner characterized E. coli mutants by seeking alterations in the sequences of the 
messenger RNA produced by the mutated genes. 
 
The members of Sanger’s group during the 1960s kept shifting from pure 
biochemistry to a more general biological specialization. Alan Coulson arrived to the 
laboratory in 1967 after finishing a degree on Applied Biology in Cambridge. 
Coulson, with Donelson, was within the group of assistants more directly involved in 
the early development of the DNA techniques. The fact that his appointment was 
more permanent made Coulson stay in the laboratory until the emergence of both, the 
plus and minus and dideoxy method, and sign the papers as co-author (1975 and 77). 
 
Sanger’s laboratory notebooks show that Coulson’s role in the “fairly ambitious” 
experiments which triggered the copying approach was decisive. Coulson was 
involved in the first attempt of using polymerase with the four DNA nucleotides and 
its further refinement between 1973 and 75. Furthermore, the emergence of the plus 
and minus method in the notebooks coincides with Donelson’s departure from the 
group after his attempt of using polymerase and gels within the degradation 
procedure. When reflecting retrospectively on the copying approach, Coulson 
considers that its success and pervasiveness was mainly due to the approach 
reproducing “the natural functioning of the cell”.112 
 
Coulson’s statement suggests that, during the first half of the 1970s, sequence 
determination shifted from its previous biochemical identity and began being 
modeled on the process of DNA replication. This problem had been a main focus of 
the neighboring molecular genetics group and Brenner, its main representative, had 
been cooperating with Sanger throughout the preceding decade. In devising the 
copying approach, Sanger and Coulson adopted the instruments and experimental 
strategies of molecular biology, dominant at the LMB and embodied in the natural 
division of the cell. 
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Sanger’s immersion in molecular biology, though, was gradual and started with his 
move to the LMB. Shortly after this, he began using as the main publishing medium 
of his papers the Journal of Molecular Biology instead of the Biochemical Journal, 
where he had published most of his protein work. The Journal of Molecular Biology 
had been founded by another LMB member, John Kendrew, becoming the reference 
publication for researchers in the new field. There, Sanger published his RNA and 
DNA techniques, and the references to problems of molecular biology – such as 
protein synthesis or cell division – increased throughout the 1960s and 70s. A 1975 
lecture delivered shortly after the publication of his plus and minus method started 
with the following statement: 
 
“DNA, the chemical component of the gene, plays a central role in biology and contains the 
whole information for the development of an organism, coded in the form of sequences of the 
four nucleotide residues.113 The lecture describes the development and application of some 
methods that can be employed to deduce sequences in these very large molecules”.114 
 
Sanger has argued that he assumed this language and problems for them being the 
“gospel” of molecular biology. According to this, he just referred to the concepts and 
concerns of his new home institution, without their affecting his working procedures. 
In his experiments, Sanger claims, “it did not really matter” how he was “thinking on 
DNA.” The really important issue was the development of sequencing methods 
through the adoption of the available technologies.115 
 
It is probably true that Sanger was unaware of his transition to molecular biology. 
However, an analysis of his copying procedure shows that it decisively affected the 
development of sequencing as a practice. Firstly, in both the plus and minus and 
dideoxy methods, Sanger used part of the DNA nucleotides and the polymerase of E. 
coli, the same model organism as Brenner and Jacob. 116  Secondly, instead of 
chemically intervening in the DNA template by breaking it with acids or enzymes, he 
just left polymerase to act on the molecule and to reproduce the natural process of 
DNA replication. Thirdly, as Brenner and Jacob had done with the E. coli mutations, 
Sanger directed the replication process towards his desired outcome by selectively 
stopping the action of polymerase on the DNA template. Fourthly, he introduced 
radioactive labeling and electrophoresis for the purpose of visualizing the sequences, 
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without having to chemically analyze them. And, finally, around 1975 Sanger started 
applying his methods to the DNA of a living organism, the virus ØX-174, of the same 
type (bacteriophage) of those Brenner and Crick had used in their late 1950s genetic 
code experiments.117 
 
Sanger was, hence, incorporating into the practice of sequencing the methodology, 
instruments and problems that molecular biologists had used in the study of cell 
division. The development of his DNA copying approach was triggered by a 
transition from the working procedures of chemistry to those of molecular biology, 
embodied in the molecular genetics group of the LMB, his new home institution.118 
While during the 1960s Sanger had kept within the parameters of analytical and 
synthetic chemistry, the contact with Brenner’s research questions and role of 
assistants such as Coulson led him to introduce replication as the basis of DNA 
sequencing the following decade. This made DNA sequencing different from the 
previous techniques, modeled on the opposite process of chemical degradation. 
 
Sanger’s sequencing methods, however, still maintained some of its original chemical 
features. The DNA template, firstly, was not replicated in vivo, but in vitro and the 
development of the dideoxy method – in which the nucleotides were modified to stop 
the action of polymerase (see note 47) – required a large amount of analytical and 
synthetic chemistry. Secondly, unless the DNA was unusually short, the molecule 
needed to be cleaved previously with enzymes in overlapping fragments. These 
fragments were then sequenced independently through the copying procedure and, 
finally, reconstructed. Sanger, thus, kept part of the original biochemical identity of 
sequencing within the copying approach. 
 
Other researchers developing alternative sequencing methods during the 1970s 
combined biochemistry and molecular biology differently. Nevertheless, Sanger’s 
combination better satisfied the necessities of molecular biologists, who felt more 
comfortable with processes involving replication through polymerase than 
degradation using chemicals. This partially accounts for the pervasiveness of 
Sanger’s techniques in the 80s and their dominance over rival methods. 
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-2.7.Rival attempts and the idea of elegance. 
 
At the same time Sanger was developing his plus and minus and dideoxy methods, an 
alternative approach to DNA sequencing was being invented in the United States by 
Walter Gilbert with the help of Allan Maxam. Gilbert was a molecular biologist based 
in Harvard, where he had been working with Watson on the genetic code. 
Nevertheless, he had a strong interest in chemistry and the development of his 
sequencing techniques was inspired by the Soviet biochemist Andrei Mirzabekov, 
who was visiting Gilbert’s laboratory in 1975.119 
 
This meant that Gilbert’s technique combined chemistry and biology in different 
proportions than at the LMB. Gilbert, as Sanger, used radioactive labeling and gel 
electrophoresis to produce a band pattern which did not need to be chemically 
analyzed. However, instead of applying polymerase, he submitted the DNA sample to 
chemicals which specifically cleaved the molecule at each nucleotide. The idea of 
using such chemicals was specifically suggested by Mirzabekov during his 1975 visit. 
By successively cleaving four groups of identical DNA samples at adenine, cytosine, 
guanine and thymine, Gilbert obtained the same overlapping fragments which Sanger 
was achieving with polymerase. The rest of the process was the same as that of the 
LMB: the fragments were separated through electrophoresis and the sequence 
deduced from the band pattern formed on the autoradiograph.120 
 
Gilbert’s technique, despite its being available since 1975, was published in the same 
journal issue as Sanger’s dideoxy sequencing in 77. Both methods were tested in a 
number of laboratories during the late 1970s and 80s. The assessment looked initially 
favorable to Gilbert, since Sanger’s technique could only be applied to single-
stranded DNA, while the Harvard method had no such limitation. However, the 
further automation of DNA sequencing in the mid 1980s was based on Sanger’s 
procedure, which relegated Gilbert’s technique to a secondary role.121 
  
Neither researchers nor scholars have been able to explain this preference on 
technical grounds alone. Whereas Sanger talks about being “lucky,” Coulson refers to 
his boss’s method as “more elegant”.122 By elegant, he means that the procedure was 
more easily applicable to a laboratory during the late 70s and 80s. The fact that the 
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LMB was a molecular biology laboratory implied that the idea of elegance referred to 
the capacity of Sanger’s sequencing to adapt to the working procedures of this 
discipline, wherein the bulk of its early users were found. 
 
This leads, again, to Coulson’s remark that Sanger’s sequencing reproduced the 
natural functioning of the cell. Researchers in molecular biology were used to these 
sort of procedures, which incorporated the natural workings of DNA into their 
experiments. Brenner had used with Crick and then with Jacob the mechanisms of 
DNA expression and replication in his attempts to solve respectively the genetic code 
and cell division during the late 1950s and 60s (see Sections 2.1 and 2.6). This meant 
that, for these investigators, a technique such as Sanger’s, which used polymerase as a 
duplication agent seemed more natural and elegant than a method which degraded 
DNA with chemicals. On the contrary, Gilbert’s technique was perceived as 
compromising the security and working standards of a laboratory. Molecular 
biologists, unsurprisingly, referred to it as “the chemical method” of sequencing 
during the late 1970s and 80s.123 
 
Sanger’s sequencing was, thus, preferred for its broader engagement with the 
procedures of molecular biology, which were inspired by the natural workings of 
DNA. This led to Gilbert’s technique being progressively abandoned and to its not 
being used in the large-scale sequencing projects arising at the end of the 1980s. 
Sanger’s dideoxy method, by contrast, became the standard sequencing procedure, 
was further automated and had an increasing impact on key areas of biological 
research.124 
 
The spread of Sanger’s technique made molecular and other biological researchers 
direct their investigations increasingly towards the sequence of information in the 
DNA of different organisms and use information technologies – such as the computer 
and the database – for that endeavor. The large-scale sequencing initiatives arising in 
the late 1980s – among them the Human Genome Project – were a reflection of this 
new goal, given unprecedentedly generous funding by political and scientific 
institutions (ibid., pp. 133-48). Sanger’s sequencing, in retrospect, consequently looks 
like a technique arising from the 1970s recombinant DNA technologies and paving 
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the way to genomics, the new mapping and sequencing field. However, the history 
offered in this paper makes the development of sequencing look less straightforward. 
 
 
-4.Conclusion: sequencing and the new histories of genomics. 
 
This paper has challenged the standard accounts of Fred Sanger’s career in order to 
portray protein, RNA and DNA sequencing as distinctive practices, suitable to 
historical analysis. Its main argument, building on Soraya de Chadarevian’s 
scholarship and challenging Sanger’s autobiography as well as other popular 
accounts, is that the development of sequencing (1940 to 83) cannot be solely 
explained in the technologies Sanger had available at a given time. The research 
environments of the Dunn Institute of Biochemistry of Cambridge (UK) and the 
Laboratory of Molecular Biology (LMB) played a crucial role in Sanger’s transition 
from a degradation to a copying approach to sequencing shortly after his 1962 move 
to the latter institution. Such transition can be seen as a gradual shift from the 
working procedures of chemistry – cleavage and reconstruction of molecules – to 
those of molecular biology – use of the natural replication mechanisms of DNA. 
Sequencing, conceived in this way, emerges as a distinctive and gradually developing 
practice framed within and changing across particular research environments. 
 
Understanding Sanger’s sequencing as a practice rather than as a technique – or 
techniques – deriving from the formal development of disciplines has implications for 
the historiography of molecular biology and genomics.125 It shows that the history of 
sequencing is longer and more complex than that of molecular biology and the 
revolutions around DNA. Sequence determination, in this regard, emerged within 
protein biochemistry and did not interact with molecular biology until the late 1950s, 
more than a decade after Sanger’s initial experiments on insulin. It also spread among 
biochemists, molecular and other biological researchers, becoming a generalized 
practice developed not only by Sanger, but by his expanding assistants and 
independent researchers which included Pehr Edman, A.D. Kaiser or Ray Wu. 
 
This long and neglected history of sequencing, firstly, is a suitable case study for de 
Chadarevian and Harmke Kamminga’s model of “molecularization” of 20th century 
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life sciences (de Chadarevian and Kamminga, eds., 1998). It shows that in the 
decades following World War II, there was a two-directional interaction between 
molecular biology and other pre-existing biological practices, something that the 
traditional historiography on molecularization has overlooked (Abir-Am, 1982; Kay, 
1993; Olby, 1990). Sequencing was, consequently, shaped by the problems, 
instruments and experimental strategies operating at the LMB – as leading molecular 
biologists have claimed – but also had an impact on the way of conducting molecular 
and other forms of biology since the 1960s. 
 
Secondly, by looking at sequencing as a historicized practice, genomics emerges as 
something more than a revolutionary consequence of the recombinant DNA 
techniques. If the aims, strategies and orientation of genomics – large-scale mapping 
and sequencing – are seen from the perspective of evolving practices, they are no 
longer exclusive to the late 1980s, but rather the result of the gradual development of 
sequencing and other biological practices which predated DNA and molecular 
biology. The history of genomics, therefore, should be sought in the distinctive 
histories of such practices and not only in the celebrated molecular revolutions or the 
technological progress following the 1970s recombinant techniques. 
 
My paper is, thus, framed within an incipient historiographical trend looking at the 
diversity of 20th century biology and, more concretely, aiming to build a historical 
perspective around genomics (Gaudillière, 2002; Rheinberger and Gaudillière, 
2004ab; Suárez and Ramillon, eds., upcoming). Historians are starting to show 
“lineages” and “continuities” between the practices of genomics and those from 
evolutionary biology, natural history, comparative biochemistry or the post-Fordist 
organizational models of the factory (Suarez, 2007, 2008; Strasser, 2006a, 2008; 
Pickstone, 2007; Ramillon, 2007; Bonneuil and Gaudillière, 2007). Their accounts 
offer an alternative to the autobiographies of molecular biologists, particularly 
pervasive and which are reproduced in popular literature as a straight line of progress 
from 1953 – elucidation of the double helix of DNA – to genomics and the Human 
Genome Project (e.g. Watson, 2003; Gilbert, 1992; Cook-Deegan, 1994; Judson, 
1992). 
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This historical scholarship also expands the ongoing contemporary STS research on 
genomics. A major concern within this field is the so-called ELSA – studies on the 
Ethical, Legal and Social Aspects of genomics – not just following genomics 
research, but also making an impact on its agenda (Goven, 2008; Tutton, 2008). For 
this purpose, it is essential that current debates in the politics, economics, sociology 
and philosophy of science – e.g. gene patenting, eugenics or medical translation of 
research results – overcome the discourse constructed by the public and genomics 
researchers (e.g. Hood, 1992; Gilbert, 1992). My paper, and the historiographical 
current within which it is framed, show the potential of history to meet such an aim. 
Only by looking at the distinctive histories of the practices constituting genomics is it 
possible to see the whole scope of the construction of this field and its associated 
debates. The long history of genomics this paper has proposed is, consequently, 
essential for seriously challenging the myth of the revolutionary nature of this 
field.126 
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1 A substantial part of the investigations reported in this paper were conducted during the development 
of my PhD at the Centre for the History of Science, Imperial College, London, and a short postdoctoral 
stay at the Centre for the History of Science, University of Manchester. 
2 Sanger, 1988, pp. 1-2. 
3 De Chadarevian, 1996, 1999. 
4 E.g. Judson, 1977, 1992; Wills, 1991; Cook-Deegan, 1994. 
5 Autobiography: Sanger, 1988. Interviews: id., 1987, 1992, 2004; Lagnado, 2005; Hartley, 2004; 
Coulson, 2004; Stretton, 2002. 
6 E.g. Kevles and Hood, 1992; Sloan, 2000. 
7 Despite problems such as internalism, whiggism or technological determinism having long been 
addressed in history of science, the standard scholarship on post-World War II biology has not 
approached this phenomenon historically. On the one hand, the literature on molecular biology focuses 
on the foundational period of this discipline (1950s and 60s), considering protein sequencing only for 
its contributions to the achievements around DNA (Abir-Am, 1982, 1992; Olby, 1992 [1974], Fox 
Keller, 1995; Morange, 1998). On the other hand, histories of previous and contemporary disciplines 
such as biochemistry address only protein sequencing, with the further RNA and DNA techniques 
being a matter of molecular biology (Fruton, 1972; Kholer, 1982, Florkin, 1972). 
8 De Chadarevian, 1996, 1999. Other historical works in preparation which also address Sanger are 
those of Bruno Strasser and Sage Ross, scholar and PhD student at the Department of History, 
University of Yale. They both partially investigate Sanger’s early career to analyze the tradition of 
comparative biochemistry (Strasser, 2008; Ross, 2008). 
9 Sanger, 1988, pp. 20 and ff.; de Chadarevian, 1999, p. 203. 
10 De Chadarevian, 1996, especially pp. 382 and ff. Further initiatives in the direction of my paper are 
emerging, especially in the realm of protein sequencing. The workshop “Making Sequences Matter,” 
which took place in June 2008 at the University of Yale, explored the use of early sequencing methods 
and protein sequences by evolutionary biologists between the 1950s and 70s. 
11 My focus on scientific practice is inspired by John Pickstone’s understanding of the history of 
science, technology and medicine as the development of recurrent, changing and interacting “ways of 
knowing” and “working” – or “working knowledges” in his latest scholarship: natural history-craft, 
analysis-rationalization and experimentalism-systematic invention (Pickstone, 2001, especially pp. 7-
20; 2007). The development of sequencing as a practice involved all Pickstone’s categories. In 
incorporating them or changing the focus from one to the other, it crossed traditional disciplinary 
boundaries between the 1940s and 70s. 
12 Kay, 1993; Abir-Am, 1982; Rheinberger, 1998; de Chadarevian and Kamminga, 1998. 
13 Abir-Am and Elliot, 1999; Holmes, 2001, 2006. 
14 Weatherall and Kamminga, 1992; Kohler, 1982, pp. 73-89; Ross, 2008; Paul, 1984; Armon, 2006; 
Abir-Am, 1982, pp. 361-67. 
15 Synge and Williams, 1990; Fruton, 1992, pp. 35-36. 
16 Kohler, 1982, pp. 88-89; Weatherall and Kamminga, 1992, pp. 80-81; Gay, 2007, pp. 148-149 and 
171-172. 
17 Chibnall, 1942, p. 137. 
18 Chibnall, 1942, pp. 136-37; Florkin, 1972, vol. 30, chs. 7 and 15; Fruton, 1972, ch. 2; Kohler, 1982, 
ch. 2. 
19 Hofmeister, 1902; Fischer, 1902; Fruton, 1985, pp. 315-16, 326-330. Other important German figure 
at that time was Albrecht Kossel, who postulated “the necessity for the quantitative accounting of a 
protein” in terms of its amino acids based on Fischer and Hofmeister’s hypotheses (Fruton, 1979, p. 5). 
Chibnall, however, does not quote Kossel in his 1942 lecture on amino acid analysis. 
20 Fruton, 1979, quote p. 10. Many of these alternative structures (e.g. the cyclol hypothesis) were 
inspired by x-ray crystallography, a parallel research line aimed at the three-dimensional structure of 
proteins. Chibnall’s group, however, did not particularly interact with researchers into this field, which 
had an important school in Cambridge, with figures such as John Kendrew or Max Perutz (see notes 20 
and 29). 
21 Florkin, 1972, vol. 30, pp. 279-85; Creager, 1998, pp. 111-16; Edsall, 1979. 
22 Fruton, 1979, p. 13 and ff.; Clarke, 1944, pp. 169-70. Bergmann and Niemann’s hypothesis had been 
inspired by William Astbury, crystallographer at the University of Leeds and one of the first 
proponents of periodicity-based theories. In a mid 1930s paper, Astbury claimed that “it is exceedingly 
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uncommon (...) for molecules to be disorganized in the solid state” and that “proteins (...) are not 
simply very long, but are also periodic polypeptide chain systems” (Astbury, 1934, pp. 15 and 23).  
23 Bergmann and Niemann, 1938, pp. 582-584, quote 582. Fruton – who in his previous career as a 
biochemist worked with Bergmann – has claimed that the periodicity hypothesis was “welcomed by 
some geneticists,” since it set “a mathematical principle that might link Mendel’s laws to the structure 
of proteins” (Fruton, 1979, p. 13). The Rockefeller Institute had been a major setting for the early 
investigations on the nature of the genetic material, believed to be proteins during the 1930s and 40s. 
Phoebus Levene, former Director of the Institute’s Laboratory of Chemistry and well connected with 
Fischer, proposed the tetranucleotide hypothesis in 1910, which like the periodicity hypothesis for 
proteins postulated a repetitive parameter in the structure of nucleic acids (Olby, 1992 [1974], pp. 81 
and ff.). This, together with the will by the Rockefeller Foundation – owner of the Institute – to apply 
mathematical physics to biology, suggests that Bergmann and Levene’s hypotheses were a product of 
their time rather than unfortunate errors, as some historians have stated (e.g. ibid., pp. 81-82). 
24 Neuberger, 1939, pp. 25-26, quote p. 26; Pirie, 1939, pp. 351-53. Sanger’s PhD thesis addressed the 
metabolism of the amino acid lysine. Despite being unrelated to his later insulin work, Sanger has 
always claimed it gave him the necessary chemical expertise to develop his techniques (Sanger, 1942, 
pp. 2 and ff.). 
25 Chibnall, 1942, quotes from pp. 158 and 159. 
26 Quotes from Chibnall, 1942, p. 137 and Sanger, 1949ab. The contrast between Bergmann and 
Niemann’s mathematical approach to proteins and that of the Dunn Institute squares with a similar 
dichotomy investigated by Lily Kay in the context of the genetic code. According to her, research on 
protein synthesis during the 1950s and early 60s shifted from cryptographic methods to those of 
biochemistry, exactly as I have shown it happened with structural analysis of proteins twenty years 
before (Kay, 2000, chs. 3-6). 
27 Chibnall, quoted in Fruton, 1992, pp. 35-36. Sanger’s early methods have been widely described 
both autobiographically and by other scholars, but with a limited focus on their technical features 
(Sanger, 1959; 1988, pp. 5-11; Wills, 1991, pp. 29-33; Stretton, 2002; Fruton, 1999, pp. 215-18). The 
account I will offer, in line with the overall orientation of this paper, seeks to frame Sanger’s technical 
choices in his institutional and professional environment. Ross has also described Sanger’s early 
methods in some detail with the aim of characterizing a discipline – comparative biochemistry (Ross, 
2008). 
28 Sanger, 1988, pp. 4-5; Morris, 1998; Gordon, 1977; Martin, 1952, p. 366. 
29 Chibnall, quoted in Fruton, 1992, p. 36; de Chadarevian, 1999, p. 203; Sanger, 1945, pp. 507-515; 
1988, pp. 4-6. 
30 The number of insulin chains was a main research question at the time and the aim of Chibnall’s 
initial request to Sanger (de Chadarevian, 1999, p. 203; Chibnall, quoted in Fruton, 1992, p. 36). In 
1945, it was thought that insulin was composed by four instead of two chains. This was due to an 
estimation of its molecular weight which was higher than our present standards (Sanger, 1988, pp. 6-7; 
1949b, pp. 157-59). 
31 Sanger also describes Fischer as a fundamental source of inspiration in all his retrospective accounts 
(Sanger, 1988, pp. 1-2; 2005). His laboratory notebooks are accompanied by a volume of Fischer’s 
collective papers, given to Sanger by the German scientist’s son – H.O.L. Fischer – at a 1951 
conference in Berkeley. The volume holds the following dedication: “To Dr. Fred Sanger in 
commemoration to his impressive presentation of his wonderful results in the Chemistry of Insulin” 
(Sanger’s Laboratory Notebooks, Wellcome Trust, London, item number SA/BIO/P/5). 
32 Quotes from Sanger, 1945, p. 514 and id., 1949a, p. 563. 
33 Sanger, 1949a, pp. 564-65; 1949b, pp. 154-57. 
34 Sanger, 1949a, p. 556; 1949b, pp. 154-57, quote in 155; Wills, 1991, p. 30. 
35 Whilst focusing his investigations on insulin, Sanger simultaneously worked on other proteins, such 
as globin, edestin, hemoglobin and gramicidin (see next subsection). These investigations, which did 
not generally result in publications, have experiments devoted to them in his notebooks, and even a 
specific volume in the case of globin (Sanger’s Laboratory Notebooks, Wellcome Trust, London, 
Insulin Books 5 to 13; Book on Globin, reference number SA/BIO/P/1/1). 
36 Sanger, 1949a, p. 573. Sanger has stressed in further accounts the importance of his 1949 paper for 
the “philosophy of proteins” (Sanger, 1987a; 1992). Nevertheless, he has retrospectively forgotten 
having suggested the idea of an unpredictable structure at that time (Sanger and Dowding, 1996, p. 7). 
This, together with the lack of STS investigations on the above conclusion, is symptomatic of the 
narrowly technical approach that scholars have adopted when analyzing Sanger’s career. 
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37 The influence of the Dunn Institute’s view of protein structure in Sanger’s work has also been 
suggested by Fruton. Nevertheless, in 1952, Sanger still considered the unpredictable nature of proteins 
– and even the peptide theory – hypothetically (Fruton, 1992, pp. 43-44; 1999, pp. 215-18; 1972, p. 1). 
38 Sanger, concretely, began combining acids with enzymes in the cutting of the chains. The enzymes 
had the advantage of breaking the molecule at specific sites –e.g. between valine and alanine – and 
permitted, upon identification of the breakage point, knowledge of the structure at the beginning and 
end of each fragment –valine and alanine. This allowed the application of the degradation procedure to 
the central parts and not only to the edges of the protein (Sanger, 1951; 1953b, pp. 353-374; 1959, pp. 
1340-44; 1988, pp. 9-11). 
39 Quotes from Sanger, 1945; 1949ab; 1951ab; 1953ab and 1953b, p. 23. The transition towards the 
term “sequence” is, nevertheless, slower in Sanger’s laboratory notebooks. Whereas the term appears 
combined with concepts such as “peptides” or “chains” in the last volumes devoted to proteins, from 
1950 onwards, “sequence” becomes more prominent in those devoted to RNA and DNA, written after 
his move to the Laboratory of Molecular Biology in 1962 (Sanger’s Laboratory Notebooks, Wellcome 
Trust, London, Insulin Books 7 and ff.; RNA and DNA Books, files number SA/BIO/P/1/20 and ff.). 
This suggests that Sanger rethought his terminology when presenting his experiments in papers and, 
during the 1950s, decided to name his work homogeneously as sequence determination. The 
terminological gap between notebooks and papers is also visible in his RNA and DNA work (see 
below). 
40 Quote from Gordon, Martin and Synge, 1943; see also Weatherall and Kamminga, 1992, pp. 64-66 
and 83. The parallelisms between Sanger, Martin and Synge suggest a particular orientation in 
Cambridge’s biological centers, engaged at that time in the development of techniques to determine 
molecular structures. Cambridge’s engagement is also reflected in the influential school of x-ray 
crystallography developed there since the 1930s, with figures such as J.D. Bernal or Lawrence Bragg. 
James Watson and Francis Crick deduced the double helical structure of DNA partially from 
crystallographic pictures in Cambridge in 1953 (Olby, 1992 [1974], Part IV). Sanger, however, was not 
very interested in crystallography (see notes 7 and 29). 
41 Bergmann had also been working in the chemical industry, concretely at the Kaiser Wilhelm Institute 
for Leather Research in Dresden during the 1920s, before moving to the Rockefeller Institute (Clarke, 
1944). Sanger, in contrast, did not have any connection with industry at any time in his career, apart 
from Chibnall’s insulin project, which was funded by the pharmaceutical firms ICI and Eli Lilly (de 
Chadarevian, 1996; Gay, 2007; Weatherall and Kamminga, 1992). 
42 Martin and Synge, 1941; Consden, Gordon and Martin, 1944; Sanger, 1945, 1949a, 1988; Gordon, 
1977; Smith, 1977; Pedersen, 1983. Research stays in Tiselius’s laboratory learning separation methods 
were common initiatives in biochemistry from the 1930s onwards and resulted in multiple transfers of 
techniques from Uppsala to Cambridge and other European and North-American institutions (e.g. Kay, 
1988). During his stay and encounter with Synge, Sanger became familiar with ionophoresis, another 
biochemical separation technique based on the electric charge of amino acids. Sanger applied this 
method to his late insulin experiments and determination of RNA sequences during the 1960s. His first 
experiments with ionophoresis in his notebooks are labeled as having been conducted “in Uppsala” and 
bear the initials “RLMS,” referring to Richard [Laurence Millington] Synge (Sanger’s Laboratory 
Notebooks, Wellcome Trust, London, Insulin Book 3, p. 494 and Uppsala Book, reference number 
SA/BIO/P/1/6). 
43 Quotes from Gordon, Martin and Synge, 1943; Consden, Gordon and Martin, 1944, p. 224; Consden, 
Gordon, Martin and Synge, 1947, p. 1947. 
44 On gramicidin: Sanger, 1946. See also Sanger, 1951a, p. 463; 1953a, p. 353 and Sanger’s Laboratory 
Notebooks, Wellcome Trust, London, Insulin Book 4, quote from p. 681. In his study of Sanger’s early 
methods, Ross has claimed that he provided Martin and Synge with DNFB-labeled amino acids as 
controls for their gramicidin project (Ross, 2008). 
45 In his investigation of ways of knowing and working – or working knowledges – Pickstone shows how 
modern biomedicine after World War II and especially after the early 1970s reflected a renewed 
configuration of experimental, analytical and natural history traditions present in older disciplines and 
periods, such as 19th century synthetic chemistry (Pickstone, 2007, pp. 513-14). Genomics and the 
Human Genome Project may, in this regard, be seen nowadays as framed in natural history and analysis – 
i.e. classificatory and routine endeavors – despite their necessary techniques having involved “much 
experimentation” (ibid., 2001, pp. 2-3 and 9). Sanger’s early career represented such an initially 
experimental nature of sequence determination. With its spread and particularly its application, the other 
descriptive working knowledges of this practice rose, becoming an increasingly repetitive and routine 
activity. Sequence determination, in this regard, represents a particularly hybrid practice involving, on 
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the one hand, the performance of experiments and the generation of new knowledge, but, on the other, 
being a repetitive activity yielding always the same results through the routine application of methods 
(García-Sancho, 2008, pp. 37 and ff). Sequence determination, thus, shows how inappropriate categories 
such as science, technology and interdisciplinarity are for historically analyzing the 20th century, as some 
historians have argued (Edgerton, 1999, 2006; see note 70). 
46 Nevertheless, according to Fischer, chemistry and biology had increasingly followed separate paths 
during the second half of the 19th century and at that time (1907) were beginning to converge again 
(Fischer, 1907). In his classical history of biochemistry, Marcel Florkin has portrayed a similar divorce 
and reunification of both disciplines (Florkin, 1972, vol. 30, ch. 12 and ff.). 
47 Quotes from Fischer, 1907, p. 1765. The development of analytical and synthetic chemistry during 
the 19th century is the object of an ongoing PhD dissertation by Catherine Jackson at the Department of 
Science and Technology Studies of University College London (Jackson, 2007). 
48 Quotes from Fischer, 1907, pp. 1761 and 1753; Fruton, 1985, pp. 326-30. 
49 Fischer, 1907, p. 1761. 
50 Chibnall, 1942, p. 137. Bergmann edited the last volumes of the collected works of Fischer, 
published in a series of eight issues, four of which appeared after his death (Fruton, 1985, note 30). 
One of them, offered by Fischer’s son, accompanies Sanger’s laboratory notebooks (see note 14). 
51 Kohler, 1982, p. 7. 
52 A researcher happy with this change of orientation was Pirie, Sanger’s first PhD Supervisor, who had 
complained during Hopkins’s Chair for the lack of chemical contents in the department’s teaching 
program (Kohler, 1982, p. 84).  
53 Kohler, 1982, p. 89; Synge and Williams, 1992, p. 81; Weatherall and Kamminga, 1992, pp. 83-84. 
54 Sanger’s framing in the parameters of Chibnall’s group is also reflected in his little interactive 
attitude towards crystallography. His contacts with crystallographers did not achieve “the experimental 
level,” as Sanger has acknowledged in interviews (Sanger, 1988, 1992). Particularly remarkable in this 
regard was the connection between Sanger and Dorothy Hodgkin, an Oxford-based crystallographer 
working on insulin at the same time he was developing his sequence determination methods. Hodgkin 
has complained of occasional indifference of Sanger (Ferry, 1998, pp. 327-28) and the only evidence of 
contacts in Sanger’s laboratory notebooks is a letter dated August 1945 attached to the experiments. In 
it, Hodgkin and members of her group send the results of an x-ray analysis of a sample of the protein 
gramicidin S previously delivered by Sanger (Sanger’s Laboratory Notebooks, Wellcome Trust, 
London, Insulin Book 2, p. 232, attached letter; see notes 15 and 22). The relationship between Sanger 
and Hodgkin, and more generally between crystallography and protein chemistry in insulin analysis, is 
an avenue for further research. 
55 Edman, 1950, pp. 284 and 292. 
56  Quotes from Hirs, Moore and Stein, 1960, p. 633; Stein and Moore, 1972, p. 85; see also Spackman, 
Stein and Moore, 1958. The preference of Edman’s technique over Sanger’s was partially due to the 
visit of the Swedish researcher to the Rockefeller Institute in the late 1940s. There, he interacted with 
the members of Bergmann’s school, including Stein and Moore. Edman himself was involved in the 
design of an automatic apparatus performing all the steps of sequence determination and not only 
amino acid analysis during the late 1960s. In the following decade, there were a number of commercial 
machines of this sort available, namely one marketed by the firm Beckman Instruments (García-
Sancho, 2008, ch. 3; Hartley, 1970, pp. 31 and further). 
57 Sanger, 1988, p. 12. De Chadarevian has suggested certain rivalry between Sanger, and Stein and 
Moore (1996, p. 371, note 36). This may be true, especially given the linkage of the American 
researchers with Bergmann and the disagreements between the latter and Chibnall’s group over protein 
structure (see Section 1.2). Sanger has denied this, claiming that Stein and Moore were good friends of 
his, despite having different approaches to sequence determination (Sanger, personal communication, 
2005). 
58 Sanger, Hartley et al, 1959; Sanger and Milstein, 1961; Sanger, 1963. 
59 Sanger, 1988, p. 11. Sanger had originally shown resistance towards this technique, according to him 
because of suspicion that the sequence of the fragments could be altered after the labeling (Sanger, 
1988). His reluctance also relates to Sanger’s dislike of physics, the discipline from which radioactive 
labeling came (Creager and Santesmases, eds., 2006). Since his undergraduate years, Sanger had avoided 
this discipline, in which he always obtained poor results (Sanger, 1992). This dislike also explains, 
partially, his alleged indifference towards crystallography, a technique with which he seldom interacted, 
despite also seeking the structure of proteins (see note 29). 
60 Creager and Santesmases, eds., 2006; Holmes, 2001, pp. 57-60; id. 2007, pp. 154-59. 
61 Sanger, 1988, pp. 11-14; 1955; Sanger, Hartley et al, 1959; Sanger and Milstein, 1961; Sanger, 1963. 
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62 Ross, 2008; Strasser, 2008. Another influence in Sanger’s espousal of comparative methods was his 
father, Frederick Sanger, a physician who cooperated with immunologist George Nuttall in the 
comparison of blood sera in Cambridge. He died fairly young, before the start of his son’s PhD studies 
(Strasser, 2008; Sanger, 1992). 
63 Sarkar, 1992; 1998, ch. 6. Sarkar distinguishes various types of reductionism shaping biological 
explanation since classical genetics in the early 20th century. The one characteristic of molecular 
biology is physical reductionism, in which the connection between genotype and phenotype is 
established in terms of the chemical and physical interactions between the components of DNA, 
understood as a macromolecule (Sarkar, 1998, pp. 136-37). 
64 Sanger, 1988, p.11; 1987a; 1992. This situation contrasted with the results produced by Tuppy – 
Sanger’s former assistant – and Anfinsen in protein sequence comparison (Strasser, 2008). The latter 
introduced these comparative practices into evolutionary research through The Molecular Basis of 
Evolution, a book published in 1959 (Ross, 2008). One of the reasons for Sanger’s stagnation was the 
specific structure and composition of insulin, which made it unsuitable for comparisons (Strasser, 
personal communication). 
65 De Chadarevian, 2002, pp. 61 and ff. 
66 Sanger, 1987a; 2005. Other reasons in which Sanger has justified his move to the LMB are 
administrative in nature, namely the Medical Research Council being his funding body – as in the new 
center – and his not wanting to teach – the LMB researchers were exempted from such duty (Sanger, 
2005, 1992). The relative importance of all these factors in Sanger’s move will not be directly 
addressed in this paper which, in line with de Chadarevian (1996), will frame this move in a more 
general shift from biochemistry to molecular biology. I will, nevertheless, investigate in more detail the 
impact of sequence determination on molecular biology and of molecular biology on sequence 
determination as a practice (see below). 
67 For autobiographical accounts on the emergence of molecular biology see Crick, 1988; Brenner 
2001. My proposal of a shift in Sanger’s sequence determination from chemistry to biology after his 
move to the LMB links this paper to the project The Nature of Evidence: How Well Do Facts Travel?, 
recently concluded at the London School of Economics. This project included a line specifically 
dealing with biological facts conducted by Sabina Leonelli, currently based in the ESRC Centre for 
Genomics in Society, University of Exeter (Leonelli, 2008). See 
http://www.lse.ac.uk/collections/economicHistory/Research/facts/ (last accessed January 2009). 
68 De Chadarevian, 1996, 1999, 2002, ch. 7; Crick, 1988, Sanger, 1988. 
69 Olby, 1992 [1974]; Stent, 1968; Morange, 2000; de Chadarevian, 2002; Sarkar, 1998; Abir-Am, 
1982, 1992. 
70 De Chadarevian, 2002, 1996. This transformation is exemplified by Marshall Nirenberg and Heinrich 
Matthaei, biochemists at the National Institutes of Health and discoverers of the mechanism of the 
genetic code in 1961. Lily Kay’s investigation into this achievement also portrays the departure of 
molecular biology from physics and its incorporation of biochemical practices during the mid-late 50s 
(Kay, 2000, especially ch. 6). 
71 Olby, 1992 [1974]; Watson and Crick, 1953ab)Crick, 1958; de Chadarevian, 1996, pp, 375-376. 
72  Crick, 1958, pp. 138-63; Kay, 2000, ch. 4. 
73 De Chadarevian, 1996, pp. 379-82; 1999, p. 204; Ingram, 1956. Another important cooperation for 
this achievement was that between Ingram and Hermann Lehmann, a physician and medical researcher 
who collected hemoglobin variants all around the world and distributed them upon request among 
biologists and doctors. X-ray crystallographers Perutz and Kendrew were also studying the three-
dimensional structure of hemoglobin at the Cavendish (de Chadarevian, 1998, pp. 178 and ff.). 
74 De Chadarevian, 1996, 2002. 
75  Sanger, 2005; 1988, p. 14; Crick, 1988, pp. 102-107. The lectures were given by Crick, Brenner and 
Seymour Benzer, another self-declared molecular biologist visiting Cambridge from the United States 
at that time. Benzer and Ingram simultaneously taught Lehmann the protein fingerprinting techniques 
and cooperated with this scientist in the characterization of hemoglobin variant D (de Chadatevian, 
1998. p. 186; see previous note). 
76  Sanger, 2005, 1992, 2005, see note 36. Sanger’s attitude towards professional identity contrasts with 
other contemporary scientists and is a key factor in the redefinition of his sequencing techniques. On 
the one hand, he was not hostile to molecular biology as some biochemists between the 1950s and 70s 
were (e.g. Chargaff, 1978). On the other, he remained indifferent towards the expansion of the new 
discipline, unlike more enthusiastic colleagues such as Severo Ochoa (Santesmases, 2002, see note 66). 
On molecular biology, biochemistry and professional identities see Abir-Am, 1992 and de Chadarevian 
and Gaudilliere, eds., 1996. 
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77 De Chadarevian, 1996, p. 385. 
78 Quote from de Chadarevian, 1996, p. 380; Crick, 1988, pp. 102-107; Sanger, 1988, 2005. 
79 Crick and Brenner’s personalities contrast with that of Smith, the researcher Sanger cites as having 
introduced him into the problems of DNA, RNA and protein synthesis (see above). Smith, a method-
oriented scientist reluctant to visibility, was more similar to Sanger, both of them being pioneers in the 
application of paper chromatography to nucleic acids (Bretscher, 2003). 
80 Autobiographical accounts: Crick, 1988, Brenner, 2001; Watson, 1969, 2003. Popular and 
contemporary STS accounts: Judson, 1977, 1992; Wills, 1991; Cook-Deegan, 1994; Rose, 2006; 
Atkinson, Greenslade and Glasner, eds. 2007. The problem of the pervasiveness of retrospective 
accounts and of the view of a revolution is not exclusive of the historiography of molecular biology. 
Thomas Lean has shown that autobiographies of computer scientists and the application to history of 
Moore’s Law have led to the idea of inevitability when talking about the progress of computing (Lean, 
2008). Equally, Pnina Abir-Am and Clark Elliot have raised similar problems in anniversaries or 
commemorations of different scientific disciplines, among them molecular biology (Abir-Am and 
Elliot, eds., 1999, Abir-Am 1999). 
81 Quote from de Chadarevian and Kamminga eds., 1998, p. 1. See also Abir-Am, 1982; Kay, 1992; 
Olby, 1990; Fox Keller, 2000. 
82 Sanger’s Laboratory Notebooks, Wellcome Trust, London, Insulin Book 12, pp. 2377 and ff, and 
Insulin Book 13; RNA and DNA books, files number SA/BIO/P/1/20 and ff. See also Sanger, 1988, pp. 
102 and ff. 
83 Florkin, 1977, vol. 32; Gaudillière, 1992; Strasser, 2006b; Rheinberger, 1993; 1997, esp. ch. 10. 
84 Crick, 1958, p. 153. 
85 De Chadarevian and Kamminga, eds., 1998, ch. 1. 
86 Sanger, 1988, pp. 14-20. 
87 Sanger, Brownlee and Barrell, 1965; Brownlee, Sanger and Barrell, 1968. The attempts outside the 
LMB, as well as Sanger’s RNA methods, are being investigated by Jerôme Pierrel in an ongoing PhD 
dissertation at the University Louis Pasteur in Strasbourg. Apart from Sanger’s work, Pierrel has 
analyzed Walter Fiers’s determination of the RNA virus MS2, first organism with a completed 
sequence in 1976 at the University of Ghent (Pierrel, 2008; Fiers et al, 1976). Due to the completeness 
and quality of Pierrel’s work, this paper will not explore in more detail Sanger’s RNA techniques. 
88 Sanger, 1988, pp. 20-21; 1980, p. 431; Sanger and Dowding, 1996, pp. 339-344; Fruton, 1999, pp. 
412-13. 
89 Sanger, 1980, pp. 432-437; Wills, 1991, pp. 40-45. In the plus and minus method, Sanger achieved the 
selective stop of polymerase by including as loose nucleotides to be incorporated to the DNA either the 
same type of base (adenine, cytosine, guanine or thymine) or three of them, removing the other. This 
way, the enzyme would always stop at the only nucleotide included (plus method) or before the removed 
one (minus method) (Sanger and Coulson, 1975a, pp. 441-448; Sanger, 1975b, pp. 324-28).  In the 
second technique – dideoxy method – normal nucleotides were combined with chemically modified ones 
(dideoxy) able to stop the polymerase reaction at each of the four bases. This permitted the achievement 
of DNA fragments which finished alternatively at dideoxiadenine, dideoxicytosine, dideoxiguanine and 
dideoxithymine (Sanger, Nicklen and Coulson, 1977, pp. 5463-5467; Garesse, 1987, pp. 72-74; id., 1994, 
pp. 77-81). 
90 Sanger, 1988, pp. 22-24; Wills, 1991, pp. 40-45. Gel electrophoresis could be two-dimensional as 
much as paper chromatography could be one-dimensional. It all depended on whether the performed 
separation was double – first vertical and then horizontal – or single. The use of electrophoresis in 
DNA sequence determination at Sanger’s group gradually shifted from two-dimensional to one-
dimensional (see below). 
91 Quote from Sanger, 2005; see also id., 1988; 1987a; 1992. 
92 Sanger, 2005. 
93 Sanger, 1988, p. 22. 
94 Sanger’s assistants have also stressed the importance of these failed attempts and the “determination” 
of their boss in developing suitable techniques (Coulson, 2005).  
95 Sanger’s Laboratory Notebooks, Wellcome Trust, London, Insulin, RNA and DNA Books (e.g. 
Insulin Book 10, p. 2140; RNA Books, folder number SA/BIO/P/1/21, experiment number R45; DNA 
Books, file number SA/BIO/P/1/42, experiment number D80). 
96 Id., DNA Books, files number SA/BIO/P/1/40 to SA/BIO/P/1/41. See also Murray, 1970; Robertson, 
Barrell, Weith and Donelson, 1973; Sanger, Donelson, Coulson, et al, 1973. 
97 Ibid., file number SA/BIO/P/1/43, experiments number D99(7) and ff., also files number 
SA/BIO/P/1/31 to SA/BIO/P/1/34. 
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98 Holmes has applied this concept to the careers of Meselson, Stahl and Benzer, other key figures in 
the early development of molecular biology. His methodology also involved interviews and detailed 
analyses of notebooks and published papers, in order to explore how scientific trajectories evolve in a 
day-to-day basis. Holmes shares the same aim as this paper: to determine the motivations leading to 
scientific choices and to challenge retrospective accounts which reduce them to Eureka moments 
(Holmes, 2001, esp. pp. 3 and ff., 2006, esp. pp. VIII-XIX and ch. 6, pp. 220-21). On history and 
collective memory of scientists more generally see Abir-Am and Elliot, 1999.  
99 The necessity of this collective historiography was first raised by Adam Bostanci, researcher 
working on more recent developments in DNA sequence determination (Bostanci, 2004, 2005). There 
is, certainly, not a collective study, as the only available investigations focus either on Sanger (de 
Chadarevian, 1996, 1999; this paper) or on other US researchers such as Ray Wu (Onaga, 2005; see 
below). 
100 The polymerase used by Sanger’s group was, nevertheless, chemically modified, in order to make it 
suitable for the copying procedure (Coulson, personal communication, 2005). 
101 Wu and Kaiser, 1968; Wu and Taylor, 1971)Billeter, Weissmann et al, 1969. 
102 Wu and Kaiser, 1968, pp. 528-34; Wu and Taylor, 1971, pp. 496-509; Billeter and Weissmann, 
1969, pp. 1085-86. In a retrospective account, Wu has stressed his group’s role in developing the 
copying approach to DNA sequence determination, usually attributed solely to Sanger (Wu, 1994). 
103 Thurtle, 1998; Kay, 1988; Pederson, 1983; Gordon, 1977. 
104 E.g. Dingman and Peacock, 1968a; 1968b. Historian Howard Chiang has shown the different 
identities that electrophoresis was given from its invention in the 1930s up to the 60s, when it began 
being widely used by molecular biologists. The technique was originally invented as an instrument 
creating a “moving boundary” in which the separation of the molecules was not complete. During the 
1940s and 50s, researchers in medical biochemistry and protein chemistry tested different separation 
media – filter paper, starch grain and agar gel – and created the concept of “zone electrophoresis,” in 
which the separation of the molecules was differentiated in independent areas on the surface. 
Electrophoresis, Chiang concludes, acquired its current identity of “molecular-sieving” technique in the 
early 1960s, when polyacrylamide gel emerged as the preferred separation medium (Chiang, 2007). 
105 Sanger’s different use of gel electrophoresis meant that its application to sequence determination 
and the interpretation of the results required certain competencies. Rafael Garesse, a Spanish molecular 
biologist and postdoctoral fellow at the LMB during the early 1980s, has noted that both the 
preparation of the gels and the visual analysis of the bands to determine the sequence necessitated 
“much training” and were correctly achieved only “after a few attempts” (Garesse, 2005). Sequence 
determination, consequently, was becoming a practice requiring specific skills only available at certain 
laboratories. During the 1950s and 60s, the use of paper chromatography and other components of 
Sanger’s protein fingerprinting technique had also proved difficult for evolutionary biologists 
incorporating sequence determination (Ross, 2008, pp. 12 and ff.). 
106 Sanger and Coulson, 1975; Sanger, Nicklen and Coulson, 1977. Sequencing was also used by Wu in 
one of his sticky ends papers in 1971 (Wu and Taylor, 1971, p. 491), but not systematically 
incorporated to published literature until Sanger’s 1975 and 77 articles. 
107 De Chadarevian, 1996, 2002, esp. ch. 8. 
108 The will of molecular biologists to move towards new research horizons is reflected in a 1963 letter 
of Brenner to Perutz, then Director of the LMB. In it, Brenner stated that “all the classical problems of 
molecular biology” had “either been solved” or would be solved “in the next decade,” and it was, 
therefore, necessary to extend investigations “to other fields of biology.” Brenner would base on that 
letter his further 1970s research on the worm C. elegans (Brenner, 1963, p. X; García-Sancho, 2008, 
ch. 2). 
109 Brenner had already cooperated with Jacob in the discovery of messenger RNA, an achievement 
related to the investigations on the genetic code during the late 1950s and early 60s (Brenner, Jacob 
and Meselson, 1961). The decipherment of the code’s mechanism by Nirenberg and Matthaei was 
based on the synthesis of messenger RNA in the test tube and did not incorporate sequencing 
techniques (Kay, 2000, chs. 5 and 6; Matthaei and Nirenberg, 1961; Nirenberg and Matthaei, 1961). 
110 The differences in approach between biology and chemistry have also been noted by biochemist and 
Nobel Prize winner Arthur Kornberg, who defined them as “two cultures” evoking the gulf that C.P. 
Snow postulated between the humanities and natural sciences (Kornberg, 1987, p. 6888; García-
Sancho, 2008, pp. 198 and ff.). 
111 Brenner, 2001, pp. 108-115. 
112 Sanger’s Laboratory Notebooks, Wellcome Trust, London, DNA Books, file number 
SA/BIO/P/1/43, quote from experiment D93. Coulson, 2005.  
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113 Sanger introduced the term information to describe the potentialities of the DNA sequence. This 
concept, central in the development of molecular biology (Kay, 2000; Sarkar, 1996; Fox Keller, 1995, 
ch. 3; Brandt, 2005), was widely used by Brenner, Crick and other LMB researchers. Whereas Sanger’s 
protein techniques were compared with a jigsaw-puzzle game – i.e. assembling overlapping fragments 
– in his DNA papers Sanger began talking about sequences that could be “read off” (Sanger, 1975a p. 
443; 1977, p. 5463; García-Sancho, 2007a, pp. 21-24; 2007b). The role of DNA in the development of 
an organism from embryo to adult – also referred by Sanger – was a crucial concern in Brenner’s 
investigations on the worm C. elegans, conducted at the same time of the invention of the plus and 
minus, and dideoxy methods (id., 2008, ch. 2). 
114 Sanger, 1975b, p. 317. 
115 Sanger, 2005. 
116 Sanger and Coulson, 1975a, p. 443; id., 1977, p. 5463. 
117 In a recent biography of Elizabeth Blackburn – PhD student at Sanger’s laboratory – Catherine 
Brady has claimed that ØX-174 was suggested to the group by postdoctoral fellow John Sedat (Brady, 
2007, p. 27). 
118 Sanger’s immersion in molecular biology was common among biochemists between the 1960s and 
70s. María Jesús Santesmases has shown the incorporation of “genetic thinking” into Ochoa’s work 
when he was shifting his research agenda from enzymology to the genetic code in the early 60s 
(Santesmases, 2002, pp. 193-94). Other researchers, on the contrary, preferred to maintain their 
biochemical identity (Chargaff, 1978; Mullis, 1998; García-Sancho, 2008, pp. 193-205; see note 41). 
119 Gilbert, 1980, p. 409; Cook-Deegan, 1994, pp. 61-64; Sutcliffe, 1995. 
120 Maxam and Gilbert, 1977; Gilbert, 1980; Soutcliffe, 1995; Sanger and Dowding, 1996, pp. 343-44; 
Wills, 1991, pp. 45-47. 
121 Cook-Deegan, 1994, pp. 64-77; García-Sancho, 2008, ch. 3. Sanger’s technique limitation was 
partially solved in the late 1970s, through the cloning of the DNA to be sequenced (normally double-
stranded) in a single-stranded bacteriophage. This way, it was possible to obtain single-stranded DNA 
from every template (Sanger, 1988, pp. 23-24; id., 1980, pp. 437-39). The dideoxy method could not be 
directly applied to double-stranded DNA until the mid 1980s, with the advent of denaturation 
techniques for separating the DNA strands (Garesse, personal communication, 2005). 
122 Sanger, 2005; Coulson, 2005. 
123 E.g. Garesse, 1987, 1994. This situation points to another extra-technological factor in the 
development of sequencing: the specifics of DNA. The capacity of this molecule for expressing and 
duplicating itself made that first molecular biologists and then Sanger incorporated those mechanisms, 
considering them the natural and elegant way of sequencing and researching on DNA. Proteins and RNA 
lacked this capacity of self-replication and needed to be investigated through other procedures, such as 
chemical degradation. 
124 García-Sancho, 2008, chs. 2-3. The field of protein sequence determination witnessed the opposite 
process: Edman’s method was preferred over Sanger’s since the late 1950s. This may, equally, be due 
to Edman’s technique being better adapted to the working procedures of biochemistry. Edman had 
previously developed links with the Rockefeller Institute – a leading center in this field – and, 
crucially, with Stein and Moore, the initiators of the automation of protein sequence determination (see 
note 30).  
125 The demarcation between practices and disciplines has also consequences for the general 
historiography of science. This distinction is the basis for John Pickstone’s “new history of science, 
technology and medicine,” based on interacting “ways of knowing” and “working” which after the 19th 
century do not correspond with disciplinary boundaries (Pickstone, 2001, 2007, see note 5). David 
Edgerton has equally noted that the separation between science and technology, as well as categories 
such as interdisciplinarity, are no longer tenable for analyzing historically the 20th century (Edgerton, 
1999, 2006). 
126 The impact of revolutionary rhetoric on current biomedical research has been analyzed by Jane 
Calvert and Joan Fujimura when investigating systems biology: researchers have constructed the 
identity of this new field by defining it as a “revolution” with regard to genomics. Systems biology as a 
field arose barely a decade after genomics (Calvert and Fujimura, 2007). 
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